<!DOCTYPE html>
<!-- saved from url=(0091)https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_2 -->
<html class="" data-reactroot=""><script async="false" type="text/javascript" src="chrome-extension://fnjhmkhhmkbjkkabndcnnogagogbneec/in-page.js"></script><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><script src="./14.奎宁 - 搜狗科学百科_files/analytics.js.download" type="text/javascript"></script>
<script type="text/javascript">window.addEventListener('DOMContentLoaded',function(){var v=archive_analytics.values;v.service='wb';v.server_name='wwwb-app201.us.archive.org';v.server_ms=483;archive_analytics.send_pageview({});});</script>
<script type="text/javascript" src="./14.奎宁 - 搜狗科学百科_files/bundle-playback.js.download" charset="utf-8"></script>
<script type="text/javascript" src="./14.奎宁 - 搜狗科学百科_files/wombat.js.download" charset="utf-8"></script>
<script type="text/javascript">
  __wm.init("https://web.archive.org/web");
  __wm.wombat("https://baike.sogou.com/kexue/d10014.htm","20221028211208","https://web.archive.org/","web","/_static/",
	      "1666991528");
</script>
<link rel="stylesheet" type="text/css" href="./14.奎宁 - 搜狗科学百科_files/banner-styles.css">
<link rel="stylesheet" type="text/css" href="./14.奎宁 - 搜狗科学百科_files/iconochive.css">
<!-- End Wayback Rewrite JS Include -->
<meta name="save" content="history"><meta http-equiv="X-UA-Compatible" content="IE=edge"><meta name="baidu-site-verification" content="VWGb6TyYx8"><meta content="奎宁 - 搜狗科学百科" name="keywords"><meta content="搜狗科学百科是一部有着平等、协作、分享、自由理念的网络科学全书，为每一个互联网用户创造一个涵盖所有领域知识、服务的中文知识性平台。" name="description"><meta http-equiv="x-dns-prefetch-control" content="on"><meta name="server" baike="235" ip="210" env="online"><link rel="dns-prefetch" href="https://web.archive.org/web/20221028211208/https://cache.soso.com/"><link rel="dns-prefetch" href="https://web.archive.org/web/20221028211208/https://hhy.sogoucdn.com/"><link rel="dns-prefetch" href="https://web.archive.org/web/20221028211208/https://pic.baike.soso.com/"><link rel="dns-prefetch" href="https://web.archive.org/web/20221028211208/https://ugc.qpic.cn/"><link rel="dns-prefetch" href="https://web.archive.org/web/20221028211208/https://xui.ptlogin2.qq.com/"><link rel="dns-prefetch" href="https://web.archive.org/web/20221028211208/https://q1.qlogo.cn/"><link rel="dns-prefetch" href="https://web.archive.org/web/20221028211208/https://q2.qlogo.cn/"><link rel="dns-prefetch" href="https://web.archive.org/web/20221028211208/https://q3.qlogo.cn/"><link rel="dns-prefetch" href="https://web.archive.org/web/20221028211208/https://q4.qlogo.cn/"><link rel="dns-prefetch" href="https://web.archive.org/web/20221028211208/https://q.qlogo.cn/"><link rel="dns-prefetch" href="https://web.archive.org/web/20221028211208/https://img01.sogoucdn.com/"><link rel="dns-prefetch" href="https://web.archive.org/web/20221028211208/https://img02.sogoucdn.com/"><link rel="dns-prefetch" href="https://web.archive.org/web/20221028211208/https://img03.sogoucdn.com/"><link rel="dns-prefetch" href="https://web.archive.org/web/20221028211208/https://img04.sogoucdn.com/"><link rel="Shortcut Icon" href="https://web.archive.org/web/20221028211208im_/https://www.sogou.com/images/logo/new/favicon.ico?v=4"><link rel="Bookmark" href="https://www.sogou.com/images/logo/new/favicon.ico?v=4"><link href="./14.奎宁 - 搜狗科学百科_files/base_b849887.css" rel="stylesheet"><link href="./14.奎宁 - 搜狗科学百科_files/detail_378aed5.css" rel="stylesheet"><link href="./14.奎宁 - 搜狗科学百科_files/inviteAudit_7894507.css" rel="stylesheet"><link rel="stylesheet" href="./14.奎宁 - 搜狗科学百科_files/highlight.min.css"><title>奎宁 - 搜狗科学百科</title><style>.onekey-close {
	position: absolute;
	top: 16px;
	right: 16px;
	width: 24px;
	height: 24px;
	background: url(//web.archive.org/web/20221028205211/https://hhy.sogoucdn.com/js/common/hhy/sprite_wap_baike_37443f3.png) no-repeat;
	text-indent: -999em;
	background-size: 84px;
	background-position: -63px 0;
}

.onekey-login {
	position: absolute;
	top: 16.4%;
	left: 0;
	right: 0;
	width: 100%;
}

/* .onekey-login-img {
    width: 75px;
    height: 75px;
    background: url("https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/images/sprite_wap_baike.png") no-repeat;
    background-size: 100px 91px;
    background-position: 0 0;
    background-repeat: no-repeat;
    margin: 0 auto;
} */

.onekey-login-title {
	text-align: center;
	padding-bottom: 3px;
	font-size: 21px;
	font-weight: bold;
	line-height: 30px;
	color: #000;
}

.onekey-login-txt {
	text-align: center;
	font-family: PingFangSC;
	font-size: 14px;
	line-height: 20px;
	color: #8f8f8f;
}

.onekey-login-qq,
.onekey-login-wx,
.onekey-login-phone {
	display: block;
	width: 245px;
	height: 54px;
	border-radius: 45px;
	text-align: center;

	margin: 0 auto;
	font-size: 17px;
	line-height: 24px;
	color: #000;
	/* padding: 16px 77px; */
	border-radius: 12px;
	border: solid 1px #e0e0e0;
}
.onekey-qq-content,
.onekey-vx-content,
.onekey-phone-content {
	display: inline-block;
	margin-top: 16px;
}
.onekey-qq-content {
	padding: 0 5px;
}

.onekey-login-qq {
	margin-top: 48px;
	margin-bottom: 24px;
}

.onekey-login-qq:before {
	display: inline-block;
	content: "";
	width: 20px;
	height: 20px;
	background: url(//web.archive.org/web/20221028205211/https://hhy.sogoucdn.com/js/common/hhy/sprite_wap_baike_37443f3.png) no-repeat;
	background-size: 80px;
	background-position: -20px 0;
	vertical-align: top;
	margin: 17px 8px 0 0;
}

.onekey-login-wx {
	margin-bottom: 24px;
}

.onekey-login-wx:before {
	display: inline-block;
	content: "";
	width: 21px;
	height: 21px;
	background: url(//web.archive.org/web/20221028205211/https://hhy.sogoucdn.com/js/common/hhy/sprite_wap_baike_37443f3.png) no-repeat;
	background-size: 84px;
	background-position: 0 0;
	vertical-align: top;
	margin: 17px 10px 0 0;
}

.onekey-login-phone {
}

.onekey-login-phone:before {
	display: inline-block;
	content: "";
	width: 21px;
	height: 21px;
	background: url(//web.archive.org/web/20221028205211/https://hhy.sogoucdn.com/js/common/hhy/sprite_wap_baike_37443f3.png) no-repeat;
	background-size: 84px;
	background-position: -42px 0;
	vertical-align: top;
	margin: 17px 10px 0 0;
}

.onekey-fixed {
	z-index: 100;
	position: fixed;
	top: 0;
	bottom: 0;
	left: 0;
	right: 0;
	background: #fff;
	width: 100%;
	height: 100%;
}

.onekey-fixed.forbid {
	z-index: 100;
	position: fixed;
	top: auto;
	bottom: 68px;
	left: 9%;
	right: 0;
	background: rgba(0, 0, 0, 0.7);
	width: 82%;
	height: 43px;
	border-radius: 25px;
	color: #ffffff;
}
.onekey-login-title.forbid {
	text-align: center;
	padding-bottom: 3px;
	font-size: 14px;
	font-weight: normal;
	line-height: 30px;
	color: white;
}
</style><style>#login_mask {
  background: #000;
  opacity: 0.5;
  filter: alpha(opacity=50);
  position: fixed;
  /*fixed好像在哪个IE上有BUG，先用用*/
  left: 0;
  top: 0;
  z-index: 999;
  height: 100%;
}

#login_iframe_container {
  position: fixed;
  width: 550px;
  height: 360px;
  z-index: 1020;
  background-color: #ffffff;
}

@media screen and (max-width: 828px) {
  #login_iframe_container {
    top: 50% !important;
    left: 50% !important;
    transform: translate(-50%, -50%);
  }
}

#login_iframe_container.new-login {
  width: 550px;
  height: 360px;
  background-image: url(//web.archive.org/web/20221028205211/https://hhy.sogoucdn.com/js/common/hhy/background_2a4a8a6.png);
}

#login_iframe_container.new-login.no-bg {
  background: #fff;
}

#login_iframe_container.new-login .login-title {
  width: 100%;
  height: 42px;
  line-height: 42px;
  text-align: center;
  font-size: 30px;
  letter-spacing: 0.19px;
  color: #ffffff;
  margin-top: 62px;
}
#login_iframe_container.new-login .forbid-title {
  width: 100%;
  height: 42px;
  line-height: 42px;
  text-align: center;
  font-size: 24px;
  letter-spacing: 0.19px;
  color: #333333;
  margin-top: 150px;
}

#login_iframe_container.new-login.no-bg .login-title {
  color: #333333;
}

#login_iframe_container.new-login .login-subtitle {
  width: 100%;
  height: 18px;
  line-height: 18px;
  font-size: 13px;
  letter-spacing: 0.08px;
  color: #ffffff;
  text-align: center;
  margin-top: 9px;
  margin-bottom: 43px;
}

#login_iframe_container.new-login.no-bg .login-subtitle {
  color: #999999;
}

#login_iframe_container.new-login .login-subtitle::before {
  content: '';
  display: inline-block;
  width: 10px;
  height: 1px;
  background-color: #ffffff;
  position: relative;
  top: -4px;
  left: -5px;
}

#login_iframe_container.new-login .login-subtitle::after {
  content: '';
  display: inline-block;
  width: 10px;
  height: 1px;
  background-color: #ffffff;
  position: relative;
  top: -4px;
  left: 5px;
}

#login_iframe_container.new-login.no-bg .login-subtitle::before {
  background-color: #999999;
}

#login_iframe_container.new-login.no-bg .login-subtitle::after {
  background-color: #999999;
}

#login_iframe_container.new-login .close-btn {
  position: absolute;
  top: 20px;
  right: 20px;
  width: 12px;
  height: 12px;
  background: url(//web.archive.org/web/20221028205211/https://hhy.sogoucdn.com/js/common/hhy/login-sprites_e3853e5.png) -59px -10px;
  background-size: 81px 91px;
  cursor: pointer;
}

#login_iframe_container.new-login .login-btn {
  width: 220px;
  height: 47px;
  border-radius: 24px;
  border: solid 1px #dddddd;
  background-color: #ffffff;
  margin: 0 auto;
  margin-top: 28px;
  position: relative;
  display: block;
}

#login_iframe_container.new-login .login-btn .login-icon {
  position: absolute;
}

#login_iframe_container.new-login .login-btn .login-text {
  width: 61px;
  height: 47px;
  line-height: 47px;
  vertical-align: middle;
  font-size: 15px;
  letter-spacing: 0.1px;
  color: #666666;
  position: absolute;
  right: 62px;
}

#login_iframe_container.new-login .login-btn.qq-btn .login-icon {
  width: 22px;
  height: 27px;
  top: 10px;
  left: 67px;
  background: url(//web.archive.org/web/20221028205211/https://hhy.sogoucdn.com/js/common/hhy/login-sprites_e3853e5.png) -10px -54px;
  background-size: 81px 91px;
}

#login_iframe_container.new-login .login-btn.qq-btn .login-text {
  right: 59px;
}

#login_iframe_container.new-login .login-btn.wechat-btn .login-icon {
  width: 29px;
  height: 24px;
  top: 12px;
  left: 62px;
  background: url(//web.archive.org/web/20221028205211/https://hhy.sogoucdn.com/js/common/hhy/login-sprites_e3853e5.png) -10px -10px;
  background-size: 81px 91px;
}</style><style>/* -- container -- */
.rodal,
.rodal-mask {
    top: 0;
    left: 0;
    width: 100%;
    height: 100%;
    z-index: 100;
}

.rodal {
    position: fixed;
}

/* -- mask -- */
.rodal-mask {
    position: fixed;
    background: rgba(0, 0, 0, .5);
}

/* -- dialog -- */
.rodal-dialog {
    position: absolute;
    z-index: 101;
    background: #fff;
    border-radius: 3px;
    box-shadow: 0 1px 3px rgba(0, 0, 0, .2);
}

.rodal-center {
    top: 50%;
    transform: translateY(-50%);
    left: 0;
    right: 0;
    margin: 0 auto;
}

.rodal-bottom {
    left: 0;
    right: 0;
    bottom: 0;
    margin: auto;
}

.rodal-top {
    left: 0;
    right: 0;
    top: 0;
    margin: auto;
}

.rodal-left {
    top: 0;
    left: 0;
    bottom: 0;
    margin: auto;
}

.rodal-right {
    top: 0;
    right: 0;
    bottom: 0;
    margin: auto;
}

/* -- close button -- */
.rodal-close {
    position: absolute;
    cursor: pointer;
    top: 16px;
    right: 16px;
    width: 16px;
    height: 16px;
}

.rodal-close:before,
.rodal-close:after {
    position: absolute;
    content: '';
    height: 2px;
    width: 100%;
    top: 50%;
    left: 0;
    margin-top: -1px;
    background: #999;
    border-radius: 100%;
    -webkit-transition: background .2s;
    transition: background .2s;
}

.rodal-close:before {
    -webkit-transform: rotate(45deg);
    transform: rotate(45deg);
}

.rodal-close:after {
    -webkit-transform: rotate(-45deg);
    transform: rotate(-45deg);
}

.rodal-close:hover:before,
.rodal-close:hover:after {
    background: #333;
}

/* -- fade -- */
/* @-webkit-keyframes rodal-fade-enter {
    from {
        opacity: 0;
    }
}

@keyframes rodal-fade-enter {
    from {
        opacity: 0;
    }
}

.rodal-fade-enter {
    -webkit-animation: rodal-fade-enter both ease-in;
    animation: rodal-fade-enter both ease-in;
} */

@-webkit-keyframes rodal-fade-leave {
    to {
        opacity: 0
    }
}

@keyframes rodal-fade-leave {
    to {
        opacity: 0
    }
}

.rodal-fade-leave {
    -webkit-animation: rodal-fade-leave both ease-out;
    animation: rodal-fade-leave both ease-out;
}

/* -- zoom -- */
@-webkit-keyframes rodal-zoom-enter {
    from {
        -webkit-transform: scale3d(.3, .3, .3);
        transform: scale3d(.3, .3, .3);
    }
}

@keyframes rodal-zoom-enter {
    from {
        -webkit-transform: scale3d(.3, .3, .3);
        transform: scale3d(.3, .3, .3);
    }
}

.rodal-zoom-enter {
    -webkit-animation: rodal-zoom-enter both cubic-bezier(0.4, 0, 0, 1.5);
    animation: rodal-zoom-enter both cubic-bezier(0.4, 0, 0, 1.5);
}

@-webkit-keyframes rodal-zoom-leave {
    to {
        -webkit-transform: scale3d(.3, .3, .3);
        transform: scale3d(.3, .3, .3);
    }
}

@keyframes rodal-zoom-leave {
    to {
        -webkit-transform: scale3d(.3, .3, .3);
        transform: scale3d(.3, .3, .3);
    }
}

.rodal-zoom-leave {
    -webkit-animation: rodal-zoom-leave both;
    animation: rodal-zoom-leave both;
}

/* -- slideDown -- */
@-webkit-keyframes rodal-slideDown-enter {
    from {
        -webkit-transform: translate3d(0, -100px, 0);
        transform: translate3d(0, -100px, 0);
    }
}

@keyframes rodal-slideDown-enter {
    from {
        -webkit-transform: translate3d(0, -100px, 0);
        transform: translate3d(0, -100px, 0);
    }
}

.rodal-slideDown-enter {
    -webkit-animation: rodal-slideDown-enter both cubic-bezier(0.4, 0, 0, 1.5);
    animation: rodal-slideDown-enter both cubic-bezier(0.4, 0, 0, 1.5);
}

@-webkit-keyframes rodal-slideDown-leave {
    to {
        -webkit-transform: translate3d(0, -100px, 0);
        transform: translate3d(0, -100px, 0);
    }
}

@keyframes rodal-slideDown-leave {
    to {
        -webkit-transform: translate3d(0, -100px, 0);
        transform: translate3d(0, -100px, 0);
    }
}

.rodal-slideDown-leave {
    -webkit-animation: rodal-slideDown-leave both;
    animation: rodal-slideDown-leave both;
}

/* -- slideLeft -- */
@-webkit-keyframes rodal-slideLeft-enter {
    from {
        -webkit-transform: translate3d(-150px, 0, 0);
        transform: translate3d(-150px, 0, 0);
    }
}

@keyframes rodal-slideLeft-enter {
    from {
        -webkit-transform: translate3d(-150px, 0, 0);
        transform: translate3d(-150px, 0, 0);
    }
}

.rodal-slideLeft-enter {
    -webkit-animation: rodal-slideLeft-enter both cubic-bezier(0.4, 0, 0, 1.5);
    animation: rodal-slideLeft-enter both cubic-bezier(0.4, 0, 0, 1.5);
}

@-webkit-keyframes rodal-slideLeft-leave {
    to {
        -webkit-transform: translate3d(-150px, 0, 0);
        transform: translate3d(-150px, 0, 0);
    }
}

@keyframes rodal-slideLeft-leave {
    to {
        -webkit-transform: translate3d(-150px, 0, 0);
        transform: translate3d(-150px, 0, 0);
    }
}

.rodal-slideLeft-leave {
    -webkit-animation: rodal-slideLeft-leave both;
    animation: rodal-slideLeft-leave both;
}

/* -- slideRight -- */
@-webkit-keyframes rodal-slideRight-enter {
    from {
        -webkit-transform: translate3d(150px, 0, 0);
        transform: translate3d(150px, 0, 0);
    }
}

@keyframes rodal-slideRight-enter {
    from {
        -webkit-transform: translate3d(150px, 0, 0);
        transform: translate3d(150px, 0, 0);
    }
}

.rodal-slideRight-enter {
    -webkit-animation: rodal-slideRight-enter both cubic-bezier(0.4, 0, 0, 1.5);
    animation: rodal-slideRight-enter both cubic-bezier(0.4, 0, 0, 1.5);
}

@-webkit-keyframes rodal-slideRight-leave {
    to {
        -webkit-transform: translate3d(150px, 0, 0);
        transform: translate3d(150px, 0, 0);
    }
}

@keyframes rodal-slideRight-leave {
    to {
        -webkit-transform: translate3d(150px, 0, 0);
        transform: translate3d(150px, 0, 0);
    }
}

.rodal-slideRight-leave {
    -webkit-animation: rodal-slideRight-leave both;
    animation: rodal-slideRight-leave both;
}

/* -- slideUp -- */
@-webkit-keyframes rodal-slideUp-enter {
    from {
        -webkit-transform: translate3d(0, 100px, 0);
        transform: translate3d(0, 100px, 0);
    }
}

@keyframes rodal-slideUp-enter {
    from {
        -webkit-transform: translate3d(0, 100px, 0);
        transform: translate3d(0, 100px, 0);
    }
}

.rodal-slideUp-enter {
    -webkit-animation: rodal-slideUp-enter both cubic-bezier(0.23, 1, 0.32, 1);
    animation: rodal-slideUp-enter both cubic-bezier(0.23, 1, 0.32, 1);
}

@-webkit-keyframes rodal-slideUp-leave {
    to {
        -webkit-transform: translate3d(0, 100px, 0);
        transform: translate3d(0, 100px, 0);
    }
}

@keyframes rodal-slideUp-leave {
    to {
        -webkit-transform: translate3d(0, 100px, 0);
        transform: translate3d(0, 100px, 0);
    }
}

.rodal-slideUp-leave {
    -webkit-animation: rodal-slideUp-leave both;
    animation: rodal-slideUp-leave both;
}

/* -- flip -- */
@-webkit-keyframes rodal-flip-enter {
    from {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, 60deg);
        transform: perspective(400px) rotate3d(1, 0, 0, 60deg);
    }

    70% {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
        transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
    }

    to {
        -webkit-transform: perspective(400px);
        transform: perspective(400px);
    }
}

@keyframes rodal-flip-enter {
    from {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, 60deg);
        transform: perspective(400px) rotate3d(1, 0, 0, 60deg);
    }

    70% {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
        transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
    }

    to {
        -webkit-transform: perspective(400px);
        transform: perspective(400px);
    }
}

.rodal-flip-enter {
    -webkit-animation: rodal-flip-enter both ease-in;
    animation: rodal-flip-enter both ease-in;
    -webkit-backface-visibility: visible !important;
    backface-visibility: visible !important;
}

@-webkit-keyframes rodal-flip-leave {
    from {
        -webkit-transform: perspective(400px);
        transform: perspective(400px);
    }

    30% {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
        transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
    }

    to {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, 45deg);
        transform: perspective(400px) rotate3d(1, 0, 0, 45deg);
    }
}

@keyframes rodal-flip-leave {
    from {
        -webkit-transform: perspective(400px);
        transform: perspective(400px);
    }

    30% {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
        transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
    }

    to {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, 45deg);
        transform: perspective(400px) rotate3d(1, 0, 0, 45deg);
    }
}

.rodal-flip-leave {
    -webkit-animation: rodal-flip-leave both;
    animation: rodal-flip-leave both;
    -webkit-backface-visibility: visible !important;
    backface-visibility: visible !important;
}

/* -- rotate -- */
@-webkit-keyframes rodal-rotate-enter {
    from {
        -webkit-transform: rotate3d(0, 0, 1, -180deg) scale3d(.3, .3, .3);
        transform: rotate3d(0, 0, 1, -180deg) scale3d(.3, .3, .3);
    }
}

@keyframes rodal-rotate-enter {
    from {
        -webkit-transform: rotate3d(0, 0, 1, -180deg) scale3d(.3, .3, .3);
        transform: rotate3d(0, 0, 1, -180deg) scale3d(.3, .3, .3);
    }
}

.rodal-rotate-enter {
    -webkit-animation: rodal-rotate-enter both;
    animation: rodal-rotate-enter both;
    -webkit-transform-origin: center;
    transform-origin: center;
}

@-webkit-keyframes rodal-rotate-leave {
    to {
        -webkit-transform: rotate3d(0, 0, 1, 180deg) scale3d(.3, .3, .3);
        transform: rotate3d(0, 0, 1, 180deg) scale3d(.3, .3, .3);
    }
}

@keyframes rodal-rotate-leave {
    to {
        -webkit-transform: rotate3d(0, 0, 1, 180deg) scale3d(.3, .3, .3);
        transform: rotate3d(0, 0, 1, 180deg) scale3d(.3, .3, .3);
    }
}

.rodal-rotate-leave {
    -webkit-animation: rodal-rotate-leave both;
    animation: rodal-rotate-leave both;
    -webkit-transform-origin: center;
    transform-origin: center;
}

/* -- door -- */
@-webkit-keyframes rodal-door-enter {
    from {
        -webkit-transform: scale3d(0, 1, 1);
        transform: scale3d(0, 1, 1);
    }
}

@keyframes rodal-door-enter {
    from {
        -webkit-transform: scale3d(0, 1, 1);
        transform: scale3d(0, 1, 1);
    }
}

.rodal-door-enter {
    -webkit-animation: rodal-door-enter both cubic-bezier(0.4, 0, 0, 1.5);
    animation: rodal-door-enter both cubic-bezier(0.4, 0, 0, 1.5);
}

@-webkit-keyframes rodal-door-leave {
    60% {
        -webkit-transform: scale3d(.01, 1, 1);
        transform: scale3d(.01, 1, 1);
    }

    to {
        -webkit-transform: scale3d(0, 1, .1);
        transform: scale3d(0, 1, .1);
    }
}

@keyframes rodal-door-leave {
    60% {
        -webkit-transform: scale3d(.01, 1, 1);
        transform: scale3d(.01, 1, 1);
    }

    to {
        -webkit-transform: scale3d(0, 1, .1);
        transform: scale3d(0, 1, .1);
    }
}

.rodal-door-leave {
    -webkit-animation: rodal-door-leave both;
    animation: rodal-door-leave both;
}</style><style>/* -- container -- */
.rodal,
.rodal-mask {
    top: 0;
    left: 0;
    width: 100%;
    height: 100%;
    z-index: 100;
}

.rodal {
    position: fixed;
}

/* -- mask -- */
.rodal-mask {
    position: fixed;
    background: rgba(0, 0, 0, .5);
}

/* -- dialog -- */
.rodal-dialog {
    position: absolute;
    z-index: 101;
    background: #fff;
    border-radius: 3px;
    box-shadow: 0 1px 3px rgba(0, 0, 0, .2);
}

.rodal-center {
    top: 50%;
    transform: translateY(-50%);
    left: 0;
    right: 0;
    margin: 0 auto;
}

.rodal-bottom {
    left: 0;
    right: 0;
    bottom: 0;
    margin: auto;
}

.rodal-top {
    left: 0;
    right: 0;
    top: 0;
    margin: auto;
}

.rodal-left {
    top: 0;
    left: 0;
    bottom: 0;
    margin: auto;
}

.rodal-right {
    top: 0;
    right: 0;
    bottom: 0;
    margin: auto;
}

/* -- close button -- */
.rodal-close {
    position: absolute;
    cursor: pointer;
    top: 16px;
    right: 16px;
    width: 16px;
    height: 16px;
}

.rodal-close:before,
.rodal-close:after {
    position: absolute;
    content: '';
    height: 2px;
    width: 100%;
    top: 50%;
    left: 0;
    margin-top: -1px;
    background: #999;
    border-radius: 100%;
    -webkit-transition: background .2s;
    transition: background .2s;
}

.rodal-close:before {
    -webkit-transform: rotate(45deg);
    transform: rotate(45deg);
}

.rodal-close:after {
    -webkit-transform: rotate(-45deg);
    transform: rotate(-45deg);
}

.rodal-close:hover:before,
.rodal-close:hover:after {
    background: #333;
}

/* -- fade -- */
/* @-webkit-keyframes rodal-fade-enter {
    from {
        opacity: 0;
    }
}

@keyframes rodal-fade-enter {
    from {
        opacity: 0;
    }
}

.rodal-fade-enter {
    -webkit-animation: rodal-fade-enter both ease-in;
    animation: rodal-fade-enter both ease-in;
} */

@-webkit-keyframes rodal-fade-leave {
    to {
        opacity: 0
    }
}

@keyframes rodal-fade-leave {
    to {
        opacity: 0
    }
}

.rodal-fade-leave {
    -webkit-animation: rodal-fade-leave both ease-out;
    animation: rodal-fade-leave both ease-out;
}

/* -- zoom -- */
@-webkit-keyframes rodal-zoom-enter {
    from {
        -webkit-transform: scale3d(.3, .3, .3);
        transform: scale3d(.3, .3, .3);
    }
}

@keyframes rodal-zoom-enter {
    from {
        -webkit-transform: scale3d(.3, .3, .3);
        transform: scale3d(.3, .3, .3);
    }
}

.rodal-zoom-enter {
    -webkit-animation: rodal-zoom-enter both cubic-bezier(0.4, 0, 0, 1.5);
    animation: rodal-zoom-enter both cubic-bezier(0.4, 0, 0, 1.5);
}

@-webkit-keyframes rodal-zoom-leave {
    to {
        -webkit-transform: scale3d(.3, .3, .3);
        transform: scale3d(.3, .3, .3);
    }
}

@keyframes rodal-zoom-leave {
    to {
        -webkit-transform: scale3d(.3, .3, .3);
        transform: scale3d(.3, .3, .3);
    }
}

.rodal-zoom-leave {
    -webkit-animation: rodal-zoom-leave both;
    animation: rodal-zoom-leave both;
}

/* -- slideDown -- */
@-webkit-keyframes rodal-slideDown-enter {
    from {
        -webkit-transform: translate3d(0, -100px, 0);
        transform: translate3d(0, -100px, 0);
    }
}

@keyframes rodal-slideDown-enter {
    from {
        -webkit-transform: translate3d(0, -100px, 0);
        transform: translate3d(0, -100px, 0);
    }
}

.rodal-slideDown-enter {
    -webkit-animation: rodal-slideDown-enter both cubic-bezier(0.4, 0, 0, 1.5);
    animation: rodal-slideDown-enter both cubic-bezier(0.4, 0, 0, 1.5);
}

@-webkit-keyframes rodal-slideDown-leave {
    to {
        -webkit-transform: translate3d(0, -100px, 0);
        transform: translate3d(0, -100px, 0);
    }
}

@keyframes rodal-slideDown-leave {
    to {
        -webkit-transform: translate3d(0, -100px, 0);
        transform: translate3d(0, -100px, 0);
    }
}

.rodal-slideDown-leave {
    -webkit-animation: rodal-slideDown-leave both;
    animation: rodal-slideDown-leave both;
}

/* -- slideLeft -- */
@-webkit-keyframes rodal-slideLeft-enter {
    from {
        -webkit-transform: translate3d(-150px, 0, 0);
        transform: translate3d(-150px, 0, 0);
    }
}

@keyframes rodal-slideLeft-enter {
    from {
        -webkit-transform: translate3d(-150px, 0, 0);
        transform: translate3d(-150px, 0, 0);
    }
}

.rodal-slideLeft-enter {
    -webkit-animation: rodal-slideLeft-enter both cubic-bezier(0.4, 0, 0, 1.5);
    animation: rodal-slideLeft-enter both cubic-bezier(0.4, 0, 0, 1.5);
}

@-webkit-keyframes rodal-slideLeft-leave {
    to {
        -webkit-transform: translate3d(-150px, 0, 0);
        transform: translate3d(-150px, 0, 0);
    }
}

@keyframes rodal-slideLeft-leave {
    to {
        -webkit-transform: translate3d(-150px, 0, 0);
        transform: translate3d(-150px, 0, 0);
    }
}

.rodal-slideLeft-leave {
    -webkit-animation: rodal-slideLeft-leave both;
    animation: rodal-slideLeft-leave both;
}

/* -- slideRight -- */
@-webkit-keyframes rodal-slideRight-enter {
    from {
        -webkit-transform: translate3d(150px, 0, 0);
        transform: translate3d(150px, 0, 0);
    }
}

@keyframes rodal-slideRight-enter {
    from {
        -webkit-transform: translate3d(150px, 0, 0);
        transform: translate3d(150px, 0, 0);
    }
}

.rodal-slideRight-enter {
    -webkit-animation: rodal-slideRight-enter both cubic-bezier(0.4, 0, 0, 1.5);
    animation: rodal-slideRight-enter both cubic-bezier(0.4, 0, 0, 1.5);
}

@-webkit-keyframes rodal-slideRight-leave {
    to {
        -webkit-transform: translate3d(150px, 0, 0);
        transform: translate3d(150px, 0, 0);
    }
}

@keyframes rodal-slideRight-leave {
    to {
        -webkit-transform: translate3d(150px, 0, 0);
        transform: translate3d(150px, 0, 0);
    }
}

.rodal-slideRight-leave {
    -webkit-animation: rodal-slideRight-leave both;
    animation: rodal-slideRight-leave both;
}

/* -- slideUp -- */
@-webkit-keyframes rodal-slideUp-enter {
    from {
        -webkit-transform: translate3d(0, 100px, 0);
        transform: translate3d(0, 100px, 0);
    }
}

@keyframes rodal-slideUp-enter {
    from {
        -webkit-transform: translate3d(0, 100px, 0);
        transform: translate3d(0, 100px, 0);
    }
}

.rodal-slideUp-enter {
    -webkit-animation: rodal-slideUp-enter both cubic-bezier(0.23, 1, 0.32, 1);
    animation: rodal-slideUp-enter both cubic-bezier(0.23, 1, 0.32, 1);
}

@-webkit-keyframes rodal-slideUp-leave {
    to {
        -webkit-transform: translate3d(0, 100px, 0);
        transform: translate3d(0, 100px, 0);
    }
}

@keyframes rodal-slideUp-leave {
    to {
        -webkit-transform: translate3d(0, 100px, 0);
        transform: translate3d(0, 100px, 0);
    }
}

.rodal-slideUp-leave {
    -webkit-animation: rodal-slideUp-leave both;
    animation: rodal-slideUp-leave both;
}

/* -- flip -- */
@-webkit-keyframes rodal-flip-enter {
    from {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, 60deg);
        transform: perspective(400px) rotate3d(1, 0, 0, 60deg);
    }

    70% {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
        transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
    }

    to {
        -webkit-transform: perspective(400px);
        transform: perspective(400px);
    }
}

@keyframes rodal-flip-enter {
    from {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, 60deg);
        transform: perspective(400px) rotate3d(1, 0, 0, 60deg);
    }

    70% {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
        transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
    }

    to {
        -webkit-transform: perspective(400px);
        transform: perspective(400px);
    }
}

.rodal-flip-enter {
    -webkit-animation: rodal-flip-enter both ease-in;
    animation: rodal-flip-enter both ease-in;
    -webkit-backface-visibility: visible !important;
    backface-visibility: visible !important;
}

@-webkit-keyframes rodal-flip-leave {
    from {
        -webkit-transform: perspective(400px);
        transform: perspective(400px);
    }

    30% {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
        transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
    }

    to {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, 45deg);
        transform: perspective(400px) rotate3d(1, 0, 0, 45deg);
    }
}

@keyframes rodal-flip-leave {
    from {
        -webkit-transform: perspective(400px);
        transform: perspective(400px);
    }

    30% {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
        transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
    }

    to {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, 45deg);
        transform: perspective(400px) rotate3d(1, 0, 0, 45deg);
    }
}

.rodal-flip-leave {
    -webkit-animation: rodal-flip-leave both;
    animation: rodal-flip-leave both;
    -webkit-backface-visibility: visible !important;
    backface-visibility: visible !important;
}

/* -- rotate -- */
@-webkit-keyframes rodal-rotate-enter {
    from {
        -webkit-transform: rotate3d(0, 0, 1, -180deg) scale3d(.3, .3, .3);
        transform: rotate3d(0, 0, 1, -180deg) scale3d(.3, .3, .3);
    }
}

@keyframes rodal-rotate-enter {
    from {
        -webkit-transform: rotate3d(0, 0, 1, -180deg) scale3d(.3, .3, .3);
        transform: rotate3d(0, 0, 1, -180deg) scale3d(.3, .3, .3);
    }
}

.rodal-rotate-enter {
    -webkit-animation: rodal-rotate-enter both;
    animation: rodal-rotate-enter both;
    -webkit-transform-origin: center;
    transform-origin: center;
}

@-webkit-keyframes rodal-rotate-leave {
    to {
        -webkit-transform: rotate3d(0, 0, 1, 180deg) scale3d(.3, .3, .3);
        transform: rotate3d(0, 0, 1, 180deg) scale3d(.3, .3, .3);
    }
}

@keyframes rodal-rotate-leave {
    to {
        -webkit-transform: rotate3d(0, 0, 1, 180deg) scale3d(.3, .3, .3);
        transform: rotate3d(0, 0, 1, 180deg) scale3d(.3, .3, .3);
    }
}

.rodal-rotate-leave {
    -webkit-animation: rodal-rotate-leave both;
    animation: rodal-rotate-leave both;
    -webkit-transform-origin: center;
    transform-origin: center;
}

/* -- door -- */
@-webkit-keyframes rodal-door-enter {
    from {
        -webkit-transform: scale3d(0, 1, 1);
        transform: scale3d(0, 1, 1);
    }
}

@keyframes rodal-door-enter {
    from {
        -webkit-transform: scale3d(0, 1, 1);
        transform: scale3d(0, 1, 1);
    }
}

.rodal-door-enter {
    -webkit-animation: rodal-door-enter both cubic-bezier(0.4, 0, 0, 1.5);
    animation: rodal-door-enter both cubic-bezier(0.4, 0, 0, 1.5);
}

@-webkit-keyframes rodal-door-leave {
    60% {
        -webkit-transform: scale3d(.01, 1, 1);
        transform: scale3d(.01, 1, 1);
    }

    to {
        -webkit-transform: scale3d(0, 1, .1);
        transform: scale3d(0, 1, .1);
    }
}

@keyframes rodal-door-leave {
    60% {
        -webkit-transform: scale3d(.01, 1, 1);
        transform: scale3d(.01, 1, 1);
    }

    to {
        -webkit-transform: scale3d(0, 1, .1);
        transform: scale3d(0, 1, .1);
    }
}

.rodal-door-leave {
    -webkit-animation: rodal-door-leave both;
    animation: rodal-door-leave both;
}</style></head><body class=""><!-- BEGIN WAYBACK TOOLBAR INSERT -->
<style type="text/css">
body {
  margin-top:0 !important;
  padding-top:0 !important;
  /*min-width:800px !important;*/
}
</style>
<script>__wm.rw(0);</script>
<div id="wm-ipp-base" lang="en" style="display: block; direction: ltr;">
</div><div id="wm-ipp-print">The Wayback Machine - https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm</div>
<script type="text/javascript">//<![CDATA[
__wm.bt(675,27,25,2,"web","https://baike.sogou.com/kexue/d10014.htm","20221028211208",1996,"/_static/",["/_static/css/banner-styles.css?v=S1zqJCYt","/_static/css/iconochive.css?v=qtvMKcIJ"], false);
  __wm.rw(1);
//]]></script>
<!-- END WAYBACK TOOLBAR INSERT --><script>window._gtag=window._gtag||{};window._gtag.shouldGrayed = false;if ('d9373eb05550416ab2f98e0854c9abc0') window._gtag.traceId = 'd9373eb05550416ab2f98e0854c9abc0';if ({"illegality":true}) window.userInfo = {"illegality":true};</script><div class="topnavbox"><ul class="topnav"><li><a href="https://web.archive.org/web/20221028211208/https://www.sogou.com/web?query=">网页</a></li><li><a href="https://web.archive.org/web/20221028211208/https://weixin.sogou.com/weixin?p=75351201">微信</a></li><li><a href="https://web.archive.org/web/20221028211208/https://zhihu.sogou.com/zhihu?p=75351218">知乎</a></li><li><a href="https://web.archive.org/web/20221028211208/https://pic.sogou.com/pics?query=">图片</a></li><li><a href="https://web.archive.org/web/20221028211208/https://v.sogou.com/v?query=">视频</a></li><li><a href="https://web.archive.org/web/20221028211208/https://mingyi.sogou.com/">医疗</a></li><li class="cur"><strong>科学</strong></li><li><a href="https://web.archive.org/web/20221028211208/https://hanyu.sogou.com/">汉语</a></li><li><a href="https://web.archive.org/web/20221028211208/https://wenwen.sogou.com/">问问</a></li><li><a href="https://web.archive.org/web/20221028211208/https://www.sogou.com/docs/more.htm">更多<span class="topraquo">»</span></a></li></ul></div><div id="header" class=""><div class="header-wrap"><a class="header-logo" href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue"></a><div class="header-search"><div class="querybox" id="suggBox"><form><input id="searchInput" class="query" type="text" placeholder="搜科学领域专业百科词条" name="query" autocomplete="off" value="" control-id="ControlID-1"><a href="javascript:;" class="query-search"></a></form></div></div><div class="header-rgt"><span class="btn-header-rgt btn-edit" id="editLemma">创建</span><div class="header-user no-login"></div></div></div></div><div class="fixed-placeholder" style="visibility:none"></div><div id="container" class=""><div class="content lemma-level1"><div class="detail-title" id="abstract-title"><h1>奎宁</h1><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#!" class="detail-edit">编辑</a></div><div class="section_content" data-id="52066609333848345"><div><p>奎宁是一种用于治疗疟疾和巴贝斯虫病的药物。<sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_1" class="kx_ref">[1]</a></sup>可用于治疗在青蒿琥酯缺乏时对氯喹具有耐药性的恶性疟原虫引起的疟疾。<sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_1" class="kx_ref">[1]</a></sup><sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_2" class="kx_ref">[2]</a></sup>虽然可以用于治疗不宁腿综合征，但由于有副作用的风险，不建议用。<sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_1" class="kx_ref">[1]</a></sup>它可以口服或静脉注射。<sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_1" class="kx_ref">[1]</a></sup>疟疾对奎宁的耐药性出现在世界某些地区。<sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_1" class="kx_ref">[1]</a></sup>奎宁也是汤力水的成分，使它具有苦味。<sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_3" class="kx_ref">[3]</a></sup>常见的副作用包括头痛、耳鸣、视力障碍和出汗。<sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_1" class="kx_ref">[1]</a></sup>更严重的副作用包括耳聋、血小板减少和心律不齐。<sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_1" class="kx_ref">[1]</a></sup>使用奎宁还会使人更容易晒伤。<sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_1" class="kx_ref">[1]</a></sup>虽然尚不清楚怀孕期间使用是否会对婴儿造成伤害，但仍建议用于治疗孕期疟疾。<sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_1" class="kx_ref">[1]</a></sup>奎宁是生物碱，一种天然存在的化合物。<sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_1" class="kx_ref">[1]</a></sup>它作为一种药物是如何起作用的还不完全清楚。<sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_1" class="kx_ref">[1]</a></sup> </p>
<p>1820年，奎宁首次从金鸡纳树的树皮中被分离出来。<sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_1" class="kx_ref">[1]</a></sup><sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_4" class="kx_ref">[4]</a></sup><sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_5" class="kx_ref">[5]</a></sup>树皮提取物至少从1632年开始就被用来治疗疟疾。<sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_6" class="kx_ref">[6]</a></sup>它被列入世界卫生组织的基本药物清单，是卫生系统所需的最有效和最安全的药物。<sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_7" class="kx_ref">[7]</a></sup>在发展中国家，奎宁的批发价约为每疗程1.70至3.40美元。<sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_8" class="kx_ref">[8]</a></sup>在美国，一个疗程的治疗费用超过200美元。<sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_9" class="kx_ref">[9]</a></sup> </p></div></div><div id="catalog"><h2 class="title2">目录<a href="javascript:" class="detail-edit">编辑</a></h2><div class="catalog_wrap" style=""><ul class="catalog_list col3"><li><span class="order">1</span><a href="javascript:" data-level="1" data-id="14994006563881480">用途</a></li><li class="secondary_catalog"><span>1.1 </span><a href="javascript:" data-id="14994006563881480">医疗</a></li><li class="secondary_catalog"><span>1.2 </span><a href="javascript:" data-id="14994006563881480">饮料</a></li><li class="secondary_catalog"><span>1.3 </span><a href="javascript:" data-id="14994006563881480">科学用途</a></li><li><span class="order">2</span><a href="javascript:" data-level="1" data-id="14994006563881481">禁忌症</a></li><li><span class="order">3</span><a href="javascript:" data-level="1" data-id="14994006580658691">不良影响</a></li></ul><ul class="catalog_list col3"><li><span class="order">4</span><a href="javascript:" data-level="1" data-id="14994006580658692">作用机理</a></li><li><span class="order">5</span><a href="javascript:" data-level="1" data-id="14994006580658693">化学</a></li><li class="secondary_catalog"><span>5.1 </span><a href="javascript:" data-id="14994006580658693">合成</a></li><li><span class="order">6</span><a href="javascript:" data-level="1" data-id="14994006580658694">生物合成</a></li><li><span class="order">7</span><a href="javascript:" data-level="1" data-id="14994006580658695">自然发生</a></li><li><span class="order">8</span><a href="javascript:" data-level="1" data-id="14994006597435916">历史</a></li></ul><ul class="catalog_list col3"><li><span class="order">9</span><a href="javascript:" data-level="1" data-id="14994006597435917">社会和文化</a></li><li class="secondary_catalog"><span>9.1 </span><a href="javascript:" data-id="14994006597435917">管理</a></li><li class="secondary_catalog"><span>9.2 </span><a href="javascript:" data-id="14994006597435917">切割剂</a></li><li><span class="order">10</span><a href="javascript:" data-level="1" data-id="14994006597435918">其他动物</a></li><li><span class="order">11</span><a href="javascript:" data-level="1" data-id="references">参考文献</a></li></ul></div></div><div id="paragraphs"><div><div id="par_14994006563881480"><h2 class="title">1 用途<a href="javascript:" class="detail-edit">编辑</a></h2><div class="section_content"><p></p><h3>1.1 <span>医疗</span></h3><p></p><p>自2006年起，世卫组织(世界卫生组织)不再建议将其作为疟疾的一线治疗方法，仅在青蒿素不可用时使用。<sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_10" class="kx_ref">[10]</a></sup><sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_11" class="kx_ref">[11]</a></sup><sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_12" class="kx_ref">[12]</a></sup><sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_13" class="kx_ref">[13]</a></sup>奎宁也用于治疗狼疮和关节炎。</p><p>在过去，奎宁经常被作为治疗夜间腿部抽筋的非标签药物，但由于食品和药物管理局警告称这种做法可能会导致危及生命的副作用，这种情况变得不那么常见了。<sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_14" class="kx_ref">[14]</a></sup> </p><p><strong>可用形式</strong></p><p>奎宁是一种碱性胺，通常以盐的形式存在。现有的各种制剂包括盐酸盐、二盐酸盐、硫酸盐、硫酸氢盐和葡萄糖酸盐。在美国，硫酸奎宁在市场上以324毫克片剂的形式出售，品牌为Qualaquin。</p><p>所有奎宁盐可以口服或静脉注射(四)；葡萄糖酸奎宁也可以肌肉注射或直肠注射。<sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_15" class="kx_ref">[15]</a></sup><sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_16" class="kx_ref">[16]</a></sup>直肠注射的主要问题是剂量在被完全吸收之前就会被排出体外；临床中，这可以通过再给一半剂量来弥补。奎宁注射制剂在美国没有被许可使用；取而代之的是奎尼丁。<sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_17" class="kx_ref">[17]</a></sup><sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_18" class="kx_ref">[18]</a></sup> </p><p>
 </p><table class="wikitable">
  <caption>
   <b>各种盐中奎宁碱含量</b> 
  </caption>
  <tbody>
   <tr>
    <th>姓名</th>
    <th>奎宁碱当量</th>
   </tr>
   <tr>
    <td>奎宁碱</td>
    <td>100毫克</td>
   </tr>
   <tr>
    <td>硫酸奎宁</td>
    <td>169毫克</td>
   </tr>
   <tr>
    <td>盐酸奎宁</td>
    <td>122毫克</td>
   </tr>
   <tr>
    <td>葡萄糖酸奎宁</td>
    <td>160毫克</td>
   </tr>
   <tr>
    <td>盐酸奎宁</td>
    <td>111毫克</td>
   </tr>
   <tr>
    <td>硫酸奎宁二水合物</td>
    <td>121毫克</td>
   </tr>
  </tbody>
 </table><p></p><p></p><h3>1.2 <span>饮料</span></h3><p></p><p></p><div class="text_img ed_imgfloat_right">
            <a class="ed_image_link lazyLoad" data-src="https://img01.sogoucdn.com/app/a/200698/sogou_science_4345" data-bigsrc="" title="点击查看大图" href="javascript:" data-observer="true" data-loaded="true" style="background-image: url(&quot;https://web.archive.org/web/20221028211208/https://img01.sogoucdn.com/app/a/200698/sogou_science_4345&quot;);"></a>
            <div class="text_img_title">奎宁水，在正常光线和紫外线“黑光”照射下。奎宁水的奎宁含量使其在黑光下发出荧光。</div>   
        </div> <p></p><p>奎宁是汤力水和苦味柠檬混合饮料的风味成分。在许多酒吧后的苏打枪上，奎宁水由代表奎宁的字母“Q”表示。<sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_19" class="kx_ref">[19]</a></sup> </p><p>根据传统，抗疟药奎宁汤剂的苦味导致在印度的英国殖民者将其与杜松子酒混合，从而创造出至今仍受欢迎的标志性杜松子奎宁鸡尾酒。如今，奎宁补剂中奎宁的含量要低得多，饮用它来治疗疟疾是没有用的。在美国，奎宁被列为一些调味Snapple饮料 (包括蔓越莓-覆盆子口味)的一种成分。</p><p>在法国，奎宁是一种叫做quinquina或"Cap Corse"的开胃酒和一种以葡萄酒为基础的开胃杜本内酒的成分。在西班牙，奎宁(“秘鲁树皮”)有时被混入甜马拉加酒，然后被称为“Malaga Quina”。在意大利，传统风味葡萄酒Barolo Chinato被注入奎宁和当地草药，并被用作餐后酒。在加拿大和意大利，奎宁是碳酸圣培露果汁饮料Brio和San Pellegrino的一种成分。在苏格兰，A.G. Barr公司使用奎宁作为碳酸饮料和含咖啡因饮料Irn-Bru的成分。在乌拉圭和阿根廷，奎宁是百事可乐公司汤力水的一种成分。在丹麦，它被用作Royal Unibrew公司生产的碳酸运动饮料Faxe Kondi的成分。</p><p>作为饮料中的调味剂，奎宁含量在美国被限制在百万分之83以下，在欧盟被限制在百万分之100毫克。<sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_20" class="kx_ref">[20]</a></sup><sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_21" class="kx_ref">[21]</a></sup><sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_22" class="kx_ref">[22]</a></sup> </p><p></p><h3>1.3 <span>科学用途</span></h3><p></p><p>奎宁(和奎尼丁)被用作手性配体，用于Sharpless不对称二羟基化中，也是许多其他手性催化剂的骨架。奎宁由于其众所周知且相对恒定的荧光量子产率，在光化学中被用作常见的荧光标准物质。 </p></div></div><div id="par_14994006563881481"><h2 class="title">2 禁忌症<a href="javascript:" class="detail-edit">编辑</a></h2><div class="section_content"><p>由于奎宁的治疗作用和毒性作用差别很小，因此奎宁是药物性疾病的常见原因，包括血小板减少症和血栓性微血管病。 即使普通饮料中含有少量奎宁，奎宁也可能对多器官系统产生严重的副作用，其中包括免疫系统效应和发烧、低血压、溶血性贫血、急性肾损伤、肝毒性和失明。 对于患有心房颤动、传导缺陷或心脏传导阻滞的患者，奎宁可导致心律失常，应避免摄入。</p><p>奎宁可导致G6PD缺乏症(一种遗传性缺陷)的溶血，但这种风险很小，当别无选择时，医生应该毫不犹豫地对UIG6PD缺乏症患者使用奎宁。 </p></div></div><div id="par_14994006580658691"><h2 class="title">3 不良影响<a href="javascript:" class="detail-edit">编辑</a></h2><div class="section_content"><p>奎宁可导致不可预测且严重危及生命的血液和心血管反应，包括血小板计数低和溶血性尿毒症综合征/血栓性血小板减少性紫癜(HUS/TTP)、长QT综合征和其他严重心律失常，包括尖端扭转型室性心动过速、黑水热、弥散性血管内凝血、白细胞减少和中性粒细胞减少。一些由于奎宁而发展成TTP的人，后来发展成肾衰竭。<sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_23" class="kx_ref">[23]</a></sup> 它还可引起严重过敏反应，包括过敏性休克、荨麻疹、严重皮疹(包括史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症)、血管性水肿、面部水肿、支气管痉挛、肉芽肿性肝炎和瘙痒。<sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_23" class="kx_ref">[23]</a></sup> </p><p>最常见的副作用包括一组称为金鸡纳病的症状，包括头痛、血管扩张和出汗、恶心、耳鸣、听力损伤、眩晕或头晕、视力模糊和色觉障碍。<sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_23" class="kx_ref">[23]</a></sup><sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_23" class="kx_ref">[23]</a></sup> 更严重的金鸡纳病包括呕吐、腹泻、腹痛、耳聋、失明和心律失常。<sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_23" class="kx_ref">[23]</a></sup> 当口服奎宁时，金鸡纳病不太常见，但口服奎宁耐受性不好(奎宁非常苦，许多患者在服用奎宁片后会呕吐):当需要口服治疗时，通常会使用其他药物，如西达 (磺胺多辛和乙胺嘧啶)或马拉酮(丙胍和阿托瓦酮)。碳酸奎宁乙酯无臭无味，<sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_23" class="kx_ref">[23]</a></sup> 但仅在日本有售。口服奎宁时，不需要血糖、电解质和心脏监测。</p></div></div><div id="par_14994006580658692"><h2 class="title">4 作用机理<a href="javascript:" class="detail-edit">编辑</a></h2><div class="section_content"><p>奎宁通过干扰疟原虫溶解和代谢血红蛋白的能力，被认为对疟疾病原体恶性疟原虫有毒性。<sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_24" class="kx_ref">[24]</a></sup>与其他喹啉抗疟药一样，奎宁的作用机制尚未完全阐明。对其作用最广泛接受的假设是基于研究充分且密切相关的喹啉药物氯喹。该模型包括抑制血红素解毒途径中的疟原虫色素生物结晶，从而促进细胞毒性血红素的聚集。游离细胞毒性血红素在寄生虫中积累，可导致它们死亡。<sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_25" class="kx_ref">[25]</a></sup>奎宁可能靶向疟疾的嘌呤核苷磷酸化酶。<sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_26" class="kx_ref">[26]</a></sup> </p></div></div><div id="par_14994006580658693"><h2 class="title">5 化学<a href="javascript:" class="detail-edit">编辑</a></h2><div class="section_content"><p></p><div class="text_img ed_imgfloat_right">
            <a class="ed_image_link lazyLoad" data-src="https://img04.sogoucdn.com/app/a/200698/sogou_science_4346" data-bigsrc="" title="点击查看大图" href="javascript:" data-observer="true" data-loaded="true" style="background-image: url(&quot;https://web.archive.org/web/20221028211208/https://img04.sogoucdn.com/app/a/200698/sogou_science_4346&quot;);"></a>
            <div class="text_img_title" style="text-align: center;">R.B .伍德沃德</div>   
        </div> <p></p><p>奎宁的紫外吸收峰值约在350纳米(长波紫外线)。荧光发射峰值约在460纳米(亮蓝色/青色)。<sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_27" class="kx_ref">[27]</a></sup>奎宁在0.1 M硫酸溶液中具有高荧光性(量子产率约为0.58)。<sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_28" class="kx_ref">[28]</a></sup><sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_28" class="kx_ref">[28]</a></sup> </p><p></p><h3>5.1 <span>合成</span></h3><p></p><p>金鸡纳树仍然是奎宁唯一经济实用的的来源。然而，在战时压力下，有许多科学家对奎宁的合成生产进行了研究。美国化学家伍德沃德和多灵于1944年完成了正式的奎宁化学合成。<sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_28" class="kx_ref">[28]</a></sup>自那以后，已经实现了几种更高效的奎宁全合成方法，<sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_29" class="kx_ref">[29]</a></sup>但是没有一种能在经济方面与从天然来源中分离奎宁相媲美。1856年，威廉·亨利·珀金在试图合成奎宁时发现了第一种合成有机染料苯胺紫。</p></div></div><div id="par_14994006580658694"><h2 class="title">6 生物合成<a href="javascript:" class="detail-edit">编辑</a></h2><div class="section_content"><p></p><div class="text_img ed_imgfloat_right">
            <a class="ed_image_link lazyLoad" data-src="https://img02.sogoucdn.com/app/a/200698/sogou_science_10696" data-bigsrc="" title="点击查看大图" href="javascript:" data-observer="true" data-loaded="true" style="background-image: url(&quot;https://web.archive.org/web/20221028211208/https://img02.sogoucdn.com/app/a/200698/sogou_science_10696&quot;);"></a>
            <div class="text_img_title" style="text-align: center;">奎宁的生物合成</div>   
        </div> <p></p><p>在奎宁生物合成的第一步中，异胡豆苷合成酶催化色胺tryptamine与secologanin之间的立体选择性Pictet-Spengler反应以产生异胡豆苷。 <sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_30" class="kx_ref">[30]</a></sup><sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_31" class="kx_ref">[31]</a></sup> 适当的修饰异胡豆苷可得到醛。水解和脱羧最初将从环烯醚萜部分除去一个碳并产生棒状鞘。然后将色胺侧链在氮附近裂解，再将该氮键与乙醛官能团结合，得到辛可卡因cinchonaminal。吲哚杂环中的开环可以产生新的胺和酮官能团。然后，通过将该胺与色胺侧链裂解中产生的醛组合，形成新的喹啉杂环，得到辛可尼酮cinchonidinone。最后一步，羟基化和甲基化得到奎宁。<sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_32" class="kx_ref">[32]</a></sup><sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_33" class="kx_ref">[33]</a></sup> </p></div></div><div id="par_14994006580658695"><h2 class="title">7 自然发生<a href="javascript:" class="detail-edit">编辑</a></h2><div class="section_content"><p>自然来源铜色树树皮含有0.5-2%的奎宁。它的树皮比金鸡纳树皮便宜。因为它有强烈的味道，所以被用来制作汤力水。<sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_34" class="kx_ref">[34]</a></sup> </p></div></div><div id="par_14994006597435916"><h2 class="title">8 历史<a href="javascript:" class="detail-edit">编辑</a></h2><div class="section_content"><p></p><div class="text_img ed_imgfloat_right">
            <a class="ed_image_link lazyLoad" data-src="https://img01.sogoucdn.com/app/a/200698/sogou_science_4347" data-bigsrc="" title="点击查看大图" href="javascript:" data-observer="true" data-loaded="true" style="background-image: url(&quot;https://web.archive.org/web/20221028211208/https://img01.sogoucdn.com/app/a/200698/sogou_science_4347&quot;);"></a>
            <div class="text_img_title" style="text-align: center;">19世纪金鸡纳树的插图</div>   
        </div> <p></p><p>奎宁也是第一种用于治疗疟疾的药物。<sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_35" class="kx_ref">[35]</a></sup> 奎宁被秘鲁、玻利维亚和厄瓜多尔土著奎丘亚人用作肌肉松弛剂，以治疗因低温而引起的颤抖。<sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_36" class="kx_ref">[36]</a></sup> 奎丘亚人会将金鸡纳树的树皮与甜味水混合，以抵消树皮的苦味，从而制作汤力水。</p><p>耶稣会士是第一个把金鸡纳带到欧洲的人。西班牙人在17世纪70年代或更早就知道金鸡纳树皮的药用价值:尼古拉斯·莫纳德斯(1571)和胡安·弗拉戈索(1572)都描述了一种后来被确定为金鸡纳树的树，其树皮被用来生产治疗腹泻的饮料。<sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_37" class="kx_ref">[37]</a></sup> 奎宁至少从17世纪早期开始就被欧洲人以未提纯的形式使用。1631年，它首次在罗马被用于治疗疟疾。在17世纪，疟疾是罗马城周围沼泽和湿地的地方病。疟疾导致了几位教皇、许多红衣主教和无数普通罗马公民的死亡。在罗马接受训练的大多数牧师都见过疟疾患者，并且熟悉该疾病发热阶段颤抖的症状。<sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_38" class="kx_ref">[38]</a></sup> 一个住在利马接受训练的药剂师，耶稣会修士阿戈斯蒂诺·萨伦比诺(1564-1642)，观察到奎丘亚人使用金鸡纳树的树皮来达到治疗疟疾的目的。虽然它在治疗疟疾(以及疟疾引起的颤抖)方面的效果与它在治疗寒颤的效果无关，但它是一种成功的抗疟疾药物。很快，萨伦比诺就派了少量人员到罗马进行疟疾治疗试验。<sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_39" class="kx_ref">[39]</a></sup> 在接下来的几年里，金鸡纳树皮，被称为耶稣会树皮或秘鲁树皮，成为从秘鲁运往欧洲的最有价值的商品之一。当查理二世国王在17世纪末用奎宁治愈疟疾时，它在伦敦开始流行起来。<sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_40" class="kx_ref">[40]</a></sup>在20世纪40年代其他药物取代它之前，它一直是首选的抗疟药。<sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_41" class="kx_ref">[41]</a></sup> </p><p>查理·玛丽·德·拉·孔达明在1737年发现了治疗疟疾最有效的奎宁。<sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_42" class="kx_ref">[42]</a></sup><sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_43" class="kx_ref">[43]</a></sup>1820年，法国研究人员皮埃尔·约瑟夫·佩尔蒂埃和约瑟夫·别奈姆·卡旺图首先从金鸡纳属的树皮中分离出奎宁，并随后用金鸡纳命名了这种物质。<sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_44" class="kx_ref">[44]</a></sup>这个名字来源于金鸡纳树皮的最初的盖丘亚(印加)单词，quina或quinaquina, 意思是“树皮的树皮”或“神圣的树皮”。在1820年之前，树皮首先被干燥，磨成细粉，然后混合成液体(通常是葡萄酒)，然后被饮用。奎宁作为疟疾预防药物的大规模使用始于1850年左右。1853年，保罗·布利特出版了《奎那》的简史和文献讨论。<sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_45" class="kx_ref">[45]</a></sup> </p><p>奎宁在欧洲人对非洲的殖民统治中发挥了重要作用。奎宁被认为是非洲不再被称为“白人坟墓”的主要原因。一位历史学家曾说过，“奎宁的功效给了殖民者涌入黄金海岸、尼日利亚和西非其他地区的新机会”。<sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_46" class="kx_ref">[46]</a></sup> </p><p>为了保持对金鸡纳树皮的垄断，秘鲁及其周边国家在19世纪初开始禁止金鸡纳种子和树苗的出口。荷兰政府仍然持续走私奎宁种子，在19世纪晚期，荷兰人在印度尼西亚种植园种植这种植物。很快他们成为了工厂的主要供应商，并在1913年成立了Kina Bureau，一个金鸡纳生产卡特尔（垄断集团），负责控制价格和生产。<sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_47" class="kx_ref">[47]</a></sup>到20世纪30年代，爪哇的荷兰种植园生产了2200万磅金鸡纳树皮，占世界奎宁产量的97%。<sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_46" class="kx_ref">[46]</a></sup>美国尝试起诉Kina Bureau，但是没有成功。<sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_47" class="kx_ref">[47]</a></sup>第二次世界大战期间，德国占领荷兰，日本在控制菲律宾和印度尼西亚的同时，切断了同盟国奎宁的供应。美国从菲律宾获得了400万颗金鸡纳种子，并开始在哥斯达黎加经营金鸡纳种植园。但这些物资来得太晚了，成千上万的美国驻非洲和南太平洋部队因缺乏奎宁而死亡。<sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_46" class="kx_ref">[46]</a></sup>尽管控制了奎宁的供应，日本人并没有有效利用奎宁，结果成千上万的日本军队在西南太平洋阵亡。<sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_48" class="kx_ref">[48]</a></sup><sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_49" class="kx_ref">[49]</a></sup><sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_50" class="kx_ref">[50]</a></sup><sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_51" class="kx_ref">[51]</a></sup>奎宁一直是抗疟疾的首选药物，直到二战后，其他副作用较少的药物，如氯喹，基本上取代了奎宁。<sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_52" class="kx_ref">[52]</a></sup> </p><p>Bromo Quinine是格罗夫实验室生产的含有奎宁的品牌感冒药。它们第一次上市是在1889年，但至少在20世纪60年代才能买到。<sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_53" class="kx_ref">[53]</a></sup> </p></div></div><div id="par_14994006597435917"><h2 class="title">9 社会和文化<a href="javascript:" class="detail-edit">编辑</a></h2><div class="section_content"><p></p><h3>9.1 <span>管理</span></h3><p></p><p>从1969年到1992年，美国食品和药物管理局(FDA)收到了157份与奎宁使用有关的健康问题报告，其中包括23份导致死亡的报告。<sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_54" class="kx_ref">[54]</a></sup>1994年，美国食品和药物管理局禁止销售非处方药奎宁来治疗夜间腿部痉挛。为此，辉瑞制药一直在出售品牌为Legatrin的药品。也作为软胶囊出售(由史密斯公司出品)。医生仍可能开含奎宁的处方，但是食品和药物管理局已经命令公司停止销售未经批准的含奎宁的药品。美国食品和药物管理局也警告消费者在使用非标签奎宁药品治疗腿部痉挛需谨慎。奎宁被批准用于治疗疟疾，但也常用于治疗腿部痉挛和类似疾病。因为疟疾威胁生命，使用奎宁治疗这种疾病的风险被认为是可以接受的。<sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_55" class="kx_ref">[55]</a></sup> </p><p>虽然Legatrin被美国食品和药物管理局禁止用于治疗腿部痉挛，但药品制造商URL Mutual已经给一种含有奎宁的药物命名为Qualaquin。它作为治疗疟疾的药物在市场上销售，在美国只能通过处方购买。2004年，美国疾病预防控制中心仅报告了1347例确诊疟疾病例。<sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_56" class="kx_ref">[56]</a></sup> </p><p></p><h3>9.2 <span>切割剂</span></h3><p></p><p>奎宁有时被发现用于可卡因和海洛因等街头毒品的切割剂。<sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_57" class="kx_ref">[57]</a></sup> </p></div></div><div id="par_14994006597435918"><h2 class="title">10 其他动物<a href="javascript:" class="detail-edit">编辑</a></h2><div class="section_content"><p>奎宁用于治疗海洋观赏鱼的刺激隐核虫(通常称为白斑、隐核或白点病)感染。<sup><a href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/d10014.htm#quote_58" class="kx_ref">[58]</a></sup> </p></div></div></div></div><div id="references"><h2 class="title" id="par_references">参考文献</h2><ul class="references"><li id="quote_1"><span class="references-num">[1]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">"Quinine Sulfate". The American Society of Health-System Pharmacists. Archived from the original on 5 December 2015. Retrieved 2 November 2017..</span></p></li><li id="quote_2"><span class="references-num">[2]</span><p class="selected"><a class="ref-back-btn">^</a><span data-url="" class="">Esu E, Effa EE, Opie ON, Uwaoma A, Meremikwu MM (September 2014). "Artemether for severe malaria". The Cochrane Database of Systematic Reviews. 9 (9): CD010678. doi:10.1002/14651858.CD010678.pub2. PMC 4455227. PMID 25209020..</span></p></li><li id="quote_3"><span class="references-num">[3]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">Olmsted J, Williams GM (1997). Chemistry: The Molecular Science (in 英语). Jones &amp; Bartlett Learning. p. 137. ISBN 978-0-815-18450-8. Archived from the original on 15 September 2016..</span></p></li><li id="quote_4"><span class="references-num">[4]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">Willcox M (28 June 2004). Traditional Medicinal Plants and Malaria. CRC Press. p. 231. ISBN 9780203502327..</span></p></li><li id="quote_5"><span class="references-num">[5]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">Cechinel-Filho V (2012). Plant bioactives and drug discovery : principles, practice, and perspectives. Hoboken, N.J.: John Wiley &amp; Sons. p. 2. ISBN 9780470582268. Archived from the original on 4 March 2016..</span></p></li><li id="quote_6"><span class="references-num">[6]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">Staines HM, Krishna S (2011). Treatment and Prevention of Malaria : Antimalarial Drug Chemistry, Action and Use. [S.l.]: Springer Verlag. p. 45. ISBN 9783034604796..</span></p></li><li id="quote_7"><span class="references-num">[7]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">"WHO Model List of Essential Medicines (19th List)" (PDF). World Health Organization. April 2015. Archived (PDF) from the original on 13 December 2016. Retrieved 8 December 2016..</span></p></li><li id="quote_8"><span class="references-num">[8]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">"Quinine Sulfate". International Drug Price Indicator Guide. Retrieved 12 January 2016..</span></p></li><li id="quote_9"><span class="references-num">[9]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">Hamilton R (2015). Tarascon Pocket Pharmacopoeia 2015 Deluxe Lab-Coat Edition. Jones &amp; Bartlett Learning. p. 47. ISBN 9781284057560..</span></p></li><li id="quote_10"><span class="references-num">[10]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">Achan J, Tibenderana JK, Kyabayinze D, Wabwire Mangen F, Kamya MR, Dorsey G, D'Alessandro U, Rosenthal PJ, Talisuna AO (July 2009). "Effectiveness of quinine versus artemether-lumefantrine for treating uncomplicated falciparum malaria in Ugandan children: randomised trial". Bmj. 339: b2763. doi:10.1136/bmj.b2763. PMC 2714631. PMID 19622553..</span></p></li><li id="quote_11"><span class="references-num">[11]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">World Health Organization (2006). "Guidelines for the treatment of malaria" (PDF). World Health Organization. Archived (PDF) from the original on 5 August 2009. Retrieved 10 August 2009..</span></p></li><li id="quote_12"><span class="references-num">[12]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">Dondorp A, Nosten F, Stepniewska K, Day N, White N (2005). "Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial". Lancet. 366 (9487): 717–25. doi:10.1016/S0140-6736(05)67176-0. PMID 16125588..</span></p></li><li id="quote_13"><span class="references-num">[13]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">Reyburn H, Mtove G, Hendriksen I, von Seidlein L (July 2009). "Oral quinine for the treatment of uncomplicated malaria" (PDF). Bmj. 339: b2066. doi:10.1136/bmj.b2066. PMID 19622550..</span></p></li><li id="quote_14"><span class="references-num">[14]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">"FDA Drug Safety Communication: New risk management plan and patient Medication Guide for Qualaquin (quinine sulfate)". Food and Drug Administration. 7 August 2010. Archived from the original on 19 February 2011. Retrieved 21 February 2011..</span></p></li><li id="quote_15"><span class="references-num">[15]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">Barennes H, Pussard E, Mahaman Sani A, Clavier F, Kahiatani F, Granic G, Henzel D, Ravinet L, Verdier F (May 1996). "Efficacy and pharmacokinetics of a new intrarectal quinine formulation in children with Plasmodium falciparum malaria". British Journal of Clinical Pharmacology. 41 (5): 389–95. doi:10.1046/j.1365-2125.1996.03246.x. PMC 2042609. PMID 8735679..</span></p></li><li id="quote_16"><span class="references-num">[16]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">Barennes H, Balima-Koussoubé T, Nagot N, Charpentier JC, Pussard E (May 2006). "Safety and efficacy of rectal compared with intramuscular quinine for the early treatment of moderately severe malaria in children: randomised clinical trial". Bmj. 332 (7549): 1055–9. doi:10.1136/bmj.332.7549.1055. PMC 1458599. PMID 16675812..</span></p></li><li id="quote_17"><span class="references-num">[17]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">Centers for Disease Control and Prevention (April 1991). "Treatment with quinidine gluconate of persons with severe Plasmodium falciparum infection: discontinuation of parenteral quinine from CDC Drug Service". MMWR. Recommendations and Reports. 40 (RR-4): 21–3. PMID 1850497..</span></p></li><li id="quote_18"><span class="references-num">[18]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">Magill A, Panosian C (July 2005). "Making antimalarial agents available in the United States". The New England Journal of Medicine. 353 (4): 335–7. doi:10.1056/NEJMp058167. PMID 16000347..</span></p></li><li id="quote_19"><span class="references-num">[19]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">Charming C (2006). Miss Charming's Guide for Hip Bartenders and Wayout Wannabes. USA: Sourcebooks, Inc. p. 189. ISBN 978-1-4022-0804-1..</span></p></li><li id="quote_20"><span class="references-num">[20]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">Ballestero JA, Plazas PV, Kracun S, Gómez-Casati ME, Taranda J, Rothlin CV, Katz E, Millar NS, et al. (September 2005). "Effects of quinine, quinidine, and chloroquine on alpha9alpha10 nicotinic cholinergic receptors". Molecular Pharmacology. 68 (3): 822–9. doi:10.1124/mol.105.014431. PMID 15955868..</span></p></li><li id="quote_21"><span class="references-num">[21]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">"Food Additive Status List". U.S. Food and Drug Administration. U.S. Department of Health and Human Services. Retrieved 9 October 2017..</span></p></li><li id="quote_22"><span class="references-num">[22]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">"COMMISSION IMPLEMENTING REGULATION (EU) No 872/2012". EUR-Lex. Official Journal of the European Union. Retrieved 9 October 2017..</span></p></li><li id="quote_23"><span class="references-num">[23]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">Liles NW, Page EE, Liles AL, Vesely SK, Raskob GE, George JN (May 2016). "Diversity and severity of adverse reactions to quinine: A systematic review". American Journal of Hematology. 91 (5): 461–6. doi:10.1002/ajh.24314. PMID 26822544..</span></p></li><li id="quote_24"><span class="references-num">[24]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">DrugBank, ed. (24 February 2017). "Quinine". DrugBank. Archived from the original on 6 February 2017..</span></p></li><li id="quote_25"><span class="references-num">[25]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">Foley M, Tilley L (February 1997). "Quinoline antimalarials: mechanisms of action and resistance". International Journal for Parasitology. 27 (2): 231–40. doi:10.1016/s0020-7519(96)00152-x. PMID 9088993..</span></p></li><li id="quote_26"><span class="references-num">[26]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">Lowe D (22 January 2019). "Quinine's Target". Science. Retrieved 28 January 2019..</span></p></li><li id="quote_27"><span class="references-num">[27]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">"Basic Concepts in Fluorescence". Archived from the original on 13 September 2012..</span></p></li><li id="quote_28"><span class="references-num">[28]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">Joseph R. Lakowicz. Principles of Fluorescence Spectroscopy Archived 1 8月 2016 at the Wayback Machine 3rd edition. Springer (2006). ISBN 978-0387-31278-1. Chapter 2. page 54..</span></p></li><li id="quote_29"><span class="references-num">[29]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">Kaufman TS, Rúveda EA (2005). "Die Jagd auf Chinin: Etappenerfolge und Gesamtsiege". Angewandte Chemie International Edition (in 德语). 117 (6): 876–907. doi:10.1002/ange.200400663..</span></p></li><li id="quote_30"><span class="references-num">[30]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">Treimer JF, Zenk MH (November 1979). "Purification and properties of strictosidine synthase, the key enzyme in indole alkaloid formation". European Journal of Biochemistry. 101 (1): 225–33. doi:10.1111/j.1432-1033.1979.tb04235.x. PMID 510306..</span></p></li><li id="quote_31"><span class="references-num">[31]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">Mizukami H, Nordlöv H, Lee SL, Scott AI (August 1979). "Purification and properties of strictosidine synthetase (an enzyme condensing tryptamine and secologanin) from Catharanthus roseus cultured cells". Biochemistry. 18 (17): 3760–3. doi:10.1021/bi00584a018. PMID 476085..</span></p></li><li id="quote_32"><span class="references-num">[32]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">Medicinal natural products : a biosynthetic approach (3rdition ed.). Wiley. pp. 380–381. ISBN 9780470742761..</span></p></li><li id="quote_33"><span class="references-num">[33]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">O'Connor SE, Maresh JJ (August 2006). "Chemistry and biology of monoterpene indole alkaloid biosynthesis". Natural Product Reports. 23 (4): 532–47. doi:10.1039/b512615k. PMID 16874388..</span></p></li><li id="quote_34"><span class="references-num">[34]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">Hobhouse H (2004). Šest rostlin, které změnily svět (in Czech). Prague: Akademie věd České republiky. p. 59. ISBN 978-80-200-1179-4.CS1 maint: Unrecognized language (link).</span></p></li><li id="quote_35"><span class="references-num">[35]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">Achan J, Talisuna AO, Erhart A, Yeka A, Tibenderana JK, Baliraine FN, Rosenthal PJ, D'Alessandro U (May 2011). "Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria". Malaria Journal. 10: 144. doi:10.1186/1475-2875-10-144. PMC 3121651. PMID 21609473..</span></p></li><li id="quote_36"><span class="references-num">[36]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">History of quinine: Friedrich A. Flückiger and Daniel Hanbury, Pharmacographia: A history of the principal drugs of vegetable origin, met with in Great Britain and British India (London, England: Macmillan and Co., 1874), pages 302-331: Cortex Cinchonæ Archived 11 11月 2014 at the Wayback Machine..</span></p></li><li id="quote_37"><span class="references-num">[37]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">See: Fernando I. Ortiz Crespo (1995) "Fragoso, Monardes and pre-Chinchonian knowledge of Cinchona," Archives of Natural History, 22 (2) : 169–181. David C. Stuart, Dangerous Garden: The Quest for Plants to Change Our Lives (London, England: Frances Lincoln Ltd., 2004), p. 28. Archived 4 6月 2016 at the Wayback Machine Nicolás Monardes, Primera, segunda y tercera partes de la Historia Medicinal de las cosas que le traen de nuestras Indias Occidentales y que sirven en Medicina [First, second and third parts of the medical history of things that have been brought from the new West Indies and that are of use in medicine] (Seville, Spain: Fernando Diaz, 1580), pp. 74-75. Archived 8 5月 2016 at the Wayback Machine From p. 74: "Del nuevo Reyno, traen una corteza, que dizen ser de un arbol, que es de mucha grandeza: el qual dize, que lleva unas hojas de forma de coraçon, y que no lleva fruto. Este arbol tiene una corteza gruessa, muy solida y dura, que en esto y en el color parece mucho a la corteza del palo que llaman Guayacan: en la superfiecie tiene una pelicula delgada blanquisca, quebrada por toda ella: tiene la corteza mas de un dedo de gruesso, solida, y pesada: la qual gustada tiene notable amargor, como el dela Genciana: tiene en el gusto notable astriction, con alguna aromaticidad, porque al fin del mascar la respira della buen olor. Tienen los Indios esta corteza en mucho, y usan de lla en todo genero de camaras, que sean con sangre, o sin ella. Los Españoles fatigados de aquesta enfermedad, por aviso de los Indios, han usado de aquesta corteza y han sanado muchos del los con ella. Toman della tanto como una hava pequeña hecha poluos, toma se en vino tinto, o en agua apropiada, como tienen la calentura, o mal: ha se de tomar por la mañana en ayunas, tres o quatro vezes: usando en lo demas, la orden y regimiento que conviene a los que tienen camaras." (From the new kingdom, there is brought a bark, which is said to be from a tree, which is very large: it is said that it bears leaves in the form of a heart, and that it bears no fruit. This tree has a thick bark, very solid and hard, that in this and in its color looks much like the bark of the tree that is called guayacán [i.e., lignum vitae]: on the surface, it has a thin, discontinuous whitish film throughout it: it has bark more than one finger thick, solid and heavy: which, when tasted, has a considerable bitterness, like that of the gentian: it has in its taste a considerable astringency, with some aromaticity, because at the end of chewing it, one breathes with a sweet odor. The Indians hold this bark in high regard, and use it for all sorts of diarrhea, that are with blood [i.e., bloody] and without it. The Spanish [who are] tired of this disease, on the advice of the Indians, have used this bark and have healed many of those with it. They take as much as a small bean, make [it into] powder, take it in red wine or in appropriate water, if they have fever or illness: it must be taken in the morning on an empty stomach, three or four times: otherwise, using the order and regimen that suits those who have diarrhea.) Fragoso, Juan, Discursos de las cosas Aromáticas, árboles y frutales, y de otras muchas medicinas simples que se traen de la India y Oriental y sirven al uso de la medicina [Discourse on fragrant things, trees and fruits, as well as many other ordinary medicines that have been brought from India and the Orient and are of use to medicine] (Madrid, Spain: Francisco Sanchez, 1572), p. 35. Archived 5 5月 2016 at the Wayback Machine From p. 35: "En el nuevo mundo ay un grande arbol que lleva las hojas a forma de coraçon, y carece de fruto. Tiene dos cortezas, la una gruessa muy solida dura, que assi en la sustancia como en el color es muy semejante al Guayacan: la otra es mas delgada y blaquezina, la qual es amarga con alguna estipticidad: y de mas desto es aromatica. Tienen la en mucho nuestros Indios, porque la usan contra qualesquier camaras, tomando de poluo peso de uno drama o poco mas, desatado en agua azerada, o vino tinto." (In the new world, there is a big tree that bears leaves in the form of a heart, and lacks fruit. It has two barks, one [is] thick, very solid, [and] hard, which in substance as well as in color is much like guayacan [i.e., lignum vitae]: the other is thinner and whitish, which is bitter with some styptic [i.e., astringent] quality: and besides this, it is aromatic. Our Indians regard it highly, because they use it against any diarrheas, taking a weight of a dram or a bit more of the powder, mixing it in mineral water, or red wine.).</span></p></li><li id="quote_38"><span class="references-num">[38]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">Juan Eusebio Nieremberg and Alonso de Andrade, Varones Ilustres en Santidad, Letras, y Zelo de las Almas. De la Compañia de Jesus. [Illustrious men in holiness, letters, and zeal for souls. Of the Society of Jesus (i.e., Jesuits).] (Madrid, Spain: Joseph Fernandez de Buendia, 1666), vol. 5, Vida del devoto Hermano Agustin Salumbrino (The life of the devout Brother Agustin Salumbrino), pp. 612–628 ; see p. 612. Archived 22 5月 2016 at the Wayback Machine From p. 612: "Nacio el Hermano Agustin Salumbrino el año de mil y quinientos y sesenta y quatro en la Ciudad de Flori en le Romania, … " (Brother Agustino Salumbrino was born in the year 1564 in the city of Flori [Note: This is an error; he was born in Forli.] in Emilia-Romagna, … ).</span></p></li><li id="quote_39"><span class="references-num">[39]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">See: Francisco Medina Rodríguez (July 2007) "Precisiones sobre la historia de la quina" Archived 4 3月 2016 at the Wayback Machine (Details about the history of quinine), Reumatología Clínica, 3 (4) : 194–196. (in Spanish) From p. 195: "De hecho, aunque no esté dicha la ultima palabra, hay escritos jesuitas que mencionan que la quina llegó a Roma en 1632, con el provincial de las missiones jusuitas del Perú, el padre Alonso Messia Venegas, como su introductor, cuando trajo una muestra de la corteza para presentaria como primicia, quien había partido de Lima 2 años antes, ya que consta que estuvo en Sevilla en 1632, donde publicó uno de sus libros y siguió su camino hacia Roma en calidad de procurador." (In fact, however, it is not the last word: there are Jesuit writings that mention that quinine arrived in Rome in 1632, with the provincial of the Jesuit missions of Peru, Father Alonso Messia Venegas, as its introducer, when he brought a sample of the bark so that it could be presented as a novelty, which had left Lima two years before, since in fact it had been in Seville in 1632, where he published one of his books and [then] he went his way toward Rome in the capacity of procurator.) Enrique Torres Saldamando, Los Antiguos Jesuitas del Perú [The old Jesuits of Peru] (Lima, Peru: Imprenta Liberal, 1882), pp. 180-191 ; see especially p. 181. Archived 10 4月 2016 at the Wayback Machine (in Spanish) From p. 181: "Al siguiente año se dirigieron á Europa los Procuradores P. Alonso Messía Venegas y P. Hernando de Leon Garavito, llevando gran cantidad de la corteza de la quina, cuyo conocimiento extendieron por el mundo los jesuitas." (In the following year [i.e., 1631] there went to Europe the procurators Father Alonso Messia Venegas and Father Hernando de Leon Garavito, taking a great quantity of cinchona bark, knowledge of which the Jesuits spread throughout the world.) Alberto Bailetti, Blog: "La Misión del Jesuita AgustÍn Salumbrino, la malaria y el árbol de quina" Archived 4 3月 2016 at the Wayback Machine (The mission of the Jesuit Agustin Salumbrino, malaria and the quinine tree), Chapter 10: La Condensa de Chinchón (The countess of Chinchon). (in Spanish) From Chapter 10: "A últimas horas de la tarde del treinta y uno de mayo de 1631 se hizo a la vela la armada real con dirección a Panamá llevando el millonario cargamento de oro y plata. En una de las naves viajaban los procuradores jesuitas padres Alonso Messia y Hernando León Garavito custodiando los fardos con la corteza de quina en polvo, preparados por Salumbrino. Después de casi veinte días de navegación el inapreciable medicamento llegó a la ciudad de Panamá, donde fue descargado para cruzar en mulas el agreste camino del itsmo palúdico hasta Portobelo para seguir a Cartagena y la Habana, cruzar el Atlántico y llegar a Sanlúcar de Barrameda en Sevilla. … Finalmente siguió su camino a Roma y a su destino final el Hospital del Espíritu Santo." (Late in the afternoon of the 31st of May, 1631, the royal armada set sail in the direction of Panama, carrying its multimillion [dollar] cargo of gold and silver. On one of the ships traveled the Jesuit procurators Fathers Alonso Messia and Hernando León Garavito, guarding the cases of powdered cinchona bark, prepared by Salumbrino. After almost 20 days of sailing, medicine arrived in the city of Panama, where it was transloaded onto mules. It then traveled the malarial isthmus as far as Portobelo, thence to Cartagena [in Colombia] and Havana. It then traveled to Sanlúcar de Barrameda in Seville, [Spain]. … Finally it followed the road to Rome and to its final destination, the Hospital of the Holy Spirit.).</span></p></li><li id="quote_40"><span class="references-num">[40]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">Rocco F (2004). Quinine: malaria and the quest for a cure that changed the world. New York, NY: Perennial..</span></p></li><li id="quote_41"><span class="references-num">[41]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">Loren H (2000). Quinine and Quarantine..</span></p></li><li id="quote_42"><span class="references-num">[42]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">de la Condamine (1738) "Sur l'arbre du quinquina" Archived 7 5月 2016 at the Wayback Machine (On the quinquina tree) Histoire de l'Académie royale des Sciences, pp. 226–243..</span></p></li><li id="quote_43"><span class="references-num">[43]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">See also: Joseph de Jussieu, Description de l'arbre à quinquina: mémoire inédit de Joseph de Jussieu (1737) Archived 19 7月 2012 at the Wayback Machine (Description of the quinquina tree: unpublished memoir of Joseph de Jussieu (1737)). De Jussieu accompanied de la Condamine on the latter's expedition to Peru..</span></p></li><li id="quote_44"><span class="references-num">[44]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">Pelletier and Caventou (1820) "Suite: Des recherches chimiques sur les quinquinas" Archived 4 5月 2016 at the Wayback Machine (Continuation: Chemical research on quinquinas), Annales de Chimie et de Physique, vol. 15, pages 337-365. The authors name quinine on page 348: " …, nous avons cru devoir la nommer quinine, pour la distinguer de la cinchonine par un nom qui indique également son origine." ( …, we thought that we should name it "quinine" in order to distinguish it from cinchonine by means of a name that also indicates its origin.).</span></p></li><li id="quote_45"><span class="references-num">[45]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">Paul Briquet (1853) Traité thérapeutique du quinquina et de ses preparations from Internet Archive.</span></p></li><li id="quote_46"><span class="references-num">[46]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">Conner, Clifford D. (2005). A People's History of Science: Miners, Midwives, and 'Low Mechanicks'. New York: Nation Books. pp. 95–96. ISBN 978-1-56025-748-6. Also cites Porter, Roy (1998). The Greatest Benefit to Mankind: A Medical History of Humanity. New York: W. W. Norton. pp. 465–466. ISBN 978-0-393-04634-2..</span></p></li><li id="quote_47"><span class="references-num">[47]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">Shah S (2010). The Fever: How Malaria Has Ruled Humankind for 500,000 Years (in 英语). Farrar, Straus and Giroux. p. 94..</span></p></li><li id="quote_48"><span class="references-num">[48]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">Louis Morton (1953). "29". The Fall of the Philippines. Washington, D.C.: United States Army. p. 524. Archived from the original on 25 May 2017..</span></p></li><li id="quote_49"><span class="references-num">[49]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">Alan Hawk. "Remembering the war in New Guinea: Japanese Medical Corps – malaria". Archived from the original on 22 November 2011..</span></p></li><li id="quote_50"><span class="references-num">[50]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">"Notes on Japanese Medical Services". Tactical and Technical Trends (36). 1943. Archived from the original on 14 October 2011..</span></p></li><li id="quote_51"><span class="references-num">[51]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">Lt. Gen. Leonard D. Heaton, ed. (1963). "8". Preventive Medicine in World War II: Volume VI, Communicable Diseases: Malaria. Washington, D.C.: Department of the Army. pp. 401 and 434. Archived from the original on 29 January 2012..</span></p></li><li id="quote_52"><span class="references-num">[52]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">Shah S (2010). The Fever: How Malaria Has Ruled Humankind for 500,000 Years (in 英语). Farrar, Straus and Giroux. p. 102..</span></p></li><li id="quote_53"><span class="references-num">[53]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">"Medicine: What's Good for a Cold?". Time. 22 February 1960. Archived from the original on 26 July 2010. Retrieved 27 April 2010..</span></p></li><li id="quote_54"><span class="references-num">[54]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">"FDA Orders Stop to Marketing Of Quinine for Night Leg Cramps". FDA Consumer Magazine. Food and Drug Administration. July–August 1995. Archived from the original on 2008-01-15. Retrieved 2009-07-31..</span></p></li><li id="quote_55"><span class="references-num">[55]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">"FDA Orders Unapproved Quinine Drugs from the Market and Cautions Consumers About Off-Label Use of Quinine to Treat Leg Cramps". United States Food and Drug Administration. 11 December 2006. Archived from the original on 28 July 2009. Retrieved 31 July 2009..</span></p></li><li id="quote_56"><span class="references-num">[56]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">"Malaria Surveillance - United States, 2004". Center for Disease Control. 22 November 2006. Archived from the original on 18 November 2009. Retrieved 22 November 2009..</span></p></li><li id="quote_57"><span class="references-num">[57]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">Microgram Bulletin, Volume 42, Number 10, October 2009 Archived 17 10月 2012 at the Wayback Machine, Page 79. Retrieved 22 September 2012..</span></p></li><li id="quote_58"><span class="references-num">[58]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">Porritt, M., Cryptocaryon irritans Archived 24 10月 2009 at the Wayback Machine, Reef Culture Magazine, 1. Retrieved 9th Jul 2009.</span></p></li></ul></div><div class="read-num">阅读 <!-- -->9921</div></div><div class="right-side" id="rightSide"><div class="side" id="lemma-side"><div class="side-title">版本记录</div><ul class="side-lst"><li><p class="side-lst-txt">暂无</p></li></ul><div class="user-card userCard"></div></div><div class="side"><div class="side-event"></div></div></div></div><div class="footer-box"><div id="footer"><div class="footer-logo-wrap"><div class="footer-logo"></div><div class="footer-logo-text">知识·传播·科普</div></div><div class="footer-info">本网站内容采用<a target="_blank" href="https://web.archive.org/web/20221028211208/https://creativecommons.org/licenses/by-sa/3.0/deed.zh?tdsourcetag=s_pctim_aiomsg">CC-BY-SA 3.0</a>授权</div><div class="footer-btn-wrap"><a target="_blank" href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/help/#user_protocol">用户协议</a><a target="_blank" href="https://web.archive.org/web/20221028211208/http://www.sogou.com/docs/terms.htm?v=1">免责声明</a><a target="_blank" href="https://web.archive.org/web/20221028211208/http://corp.sogou.com/private.html">隐私政策</a><a target="_blank" href="https://web.archive.org/web/20221028211208/https://baike.sogou.com/kexue/intro.htm">关于我们</a></div></div></div><script>window.lemmaInfo ={"lemmaId":"10014","versionId":"52066609333848333","title":"奎宁","subtitle":"","abstracts":{"paragraphId":"52066609333848345","title":"摘要","versionId":"52066609333848334","lemmaId":10014,"createType":0,"creator":{"uid":0,"name":null,"pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"createTime":0,"versionEditor":{"uid":81910391,"name":"哈哈","pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"editTime":1598330117,"comment":null,"dependVersionId":0,"contentType":2,"content":"<p>奎宁是一种用于治疗疟疾和巴贝斯虫病的药物。<sup><a href=\"#quote_1\" class=\"kx_ref\">[1]</a></sup>可用于治疗在青蒿琥酯缺乏时对氯喹具有耐药性的恶性疟原虫引起的疟疾。<sup><a href=\"#quote_1\" class=\"kx_ref\">[1]</a></sup><sup><a href=\"#quote_2\" class=\"kx_ref\">[2]</a></sup>虽然可以用于治疗不宁腿综合征，但由于有副作用的风险，不建议用。<sup><a href=\"#quote_1\" class=\"kx_ref\">[1]</a></sup>它可以口服或静脉注射。<sup><a href=\"#quote_1\" class=\"kx_ref\">[1]</a></sup>疟疾对奎宁的耐药性出现在世界某些地区。<sup><a href=\"#quote_1\" class=\"kx_ref\">[1]</a></sup>奎宁也是汤力水的成分，使它具有苦味。<sup><a href=\"#quote_3\" class=\"kx_ref\">[3]</a></sup>常见的副作用包括头痛、耳鸣、视力障碍和出汗。<sup><a href=\"#quote_1\" class=\"kx_ref\">[1]</a></sup>更严重的副作用包括耳聋、血小板减少和心律不齐。<sup><a href=\"#quote_1\" class=\"kx_ref\">[1]</a></sup>使用奎宁还会使人更容易晒伤。<sup><a href=\"#quote_1\" class=\"kx_ref\">[1]</a></sup>虽然尚不清楚怀孕期间使用是否会对婴儿造成伤害，但仍建议用于治疗孕期疟疾。<sup><a href=\"#quote_1\" class=\"kx_ref\">[1]</a></sup>奎宁是生物碱，一种天然存在的化合物。<sup><a href=\"#quote_1\" class=\"kx_ref\">[1]</a></sup>它作为一种药物是如何起作用的还不完全清楚。<sup><a href=\"#quote_1\" class=\"kx_ref\">[1]</a></sup> </p>\n<p>1820年，奎宁首次从金鸡纳树的树皮中被分离出来。<sup><a href=\"#quote_1\" class=\"kx_ref\">[1]</a></sup><sup><a href=\"#quote_4\" class=\"kx_ref\">[4]</a></sup><sup><a href=\"#quote_5\" class=\"kx_ref\">[5]</a></sup>树皮提取物至少从1632年开始就被用来治疗疟疾。<sup><a href=\"#quote_6\" class=\"kx_ref\">[6]</a></sup>它被列入世界卫生组织的基本药物清单，是卫生系统所需的最有效和最安全的药物。<sup><a href=\"#quote_7\" class=\"kx_ref\">[7]</a></sup>在发展中国家，奎宁的批发价约为每疗程1.70至3.40美元。<sup><a href=\"#quote_8\" class=\"kx_ref\">[8]</a></sup>在美国，一个疗程的治疗费用超过200美元。<sup><a href=\"#quote_9\" class=\"kx_ref\">[9]</a></sup> </p>","pics":null,"card":null,"references":[],"versionCount":0},"card":{"paragraphId":"0","title":"","versionId":"0","lemmaId":0,"createType":0,"creator":{"uid":0,"name":null,"pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"createTime":0,"versionEditor":{"uid":0,"name":null,"pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"editTime":0,"comment":null,"dependVersionId":0,"contentType":0,"content":"","pics":null,"card":null,"references":null,"versionCount":0},"categories":[{"id":3,"name":"化学","parents":[]}],"creator":{"uid":15269800,"name":"Verities","pic":"https://web.archive.org/web/20221028211208/https://cache.soso.com/qlogo/g?b=oidb&k=TLX9ibo1nDRAeZ1KiaS07B0A&s=100&t=1556368676","introduction":null,"educations":[{"schoolName":"大连理工大学","major":"","degree":"博士","universityId":40,"universityLogo":"https://web.archive.org/web/20221028211208/https://img01.sogoucdn.com/app/a/200943/4fe177fe-6012-11e9-a709-fc4dd4f70029","majorLevel1":"工学","majorLevel2":"化学工程与技术","majorLevel3":"能源化工","majorLevel1Id":353,"majorLevel2Id":684,"majorLevel3Id":714,"state":"毕业","lab":"精细化工 国家重点实验室","researchField":"电催化、质子交换膜燃料电池"}],"jobs":null,"works":null,"educationBrief":"大连理工大学","jobBrief":"","role":0,"roleName":null,"title":"大连理工大学 · 化学工程与技术博士","professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":1593568942,"partnerIdPoped":false},"createTime":1571038181,"editor":{"uid":81910391,"name":"是福不是祸","pic":"https://web.archive.org/web/20221028211208/https://cache.soso.com/qlogo/g?b=oidb&k=6iaUd8ybMyWyTRyUPWibRsLg&s=100&t=1566664174","introduction":"全幼儿园最可爱的小朋友","educations":null,"jobs":null,"works":null,"educationBrief":"","jobBrief":"","role":0,"roleName":null,"title":"","professionalTitle":"","phoneNo":null,"editable":true,"partnerId":236,"partnerIdCreateTime":1596529271,"partnerIdPoped":true},"editTime":1598330117,"state":1,"versionCount":3,"upNum":2,"downNum":0,"pics":[{"originalUrl":"https://web.archive.org/web/20221028211208/https://img01.sogoucdn.com/app/a/200698/sogou_science_4345?w=300&h=300&titlename=%E5%A5%8E%E5%AE%81%E6%B0%B4%EF%BC%8C%E5%9C%A8%E6%AD%A3%E5%B8%B8%E5%85%89%E7%BA%BF%E5%92%8C%E7%B4%AB%E5%A4%96%E7%BA%BF%E2%80%9C%E9%BB%91%E5%85%89%E2%80%9D%E7%85%A7%E5%B0%84%E4%B8%8B%E3%80%82%E5%A5%8E%E5%AE%81%E6%B0%B4%E7%9A%84%E5%A5%8E%E5%AE%81%E5%90%AB%E9%87%8F%E4%BD%BF%E5%85%B6%E5%9C%A8%E9%BB%91%E5%85%89%E4%B8%8B%E5%8F%91%E5%87%BA%E8%8D%A7%E5%85%89%E3%80%82","url":"https://web.archive.org/web/20221028211208/https://img01.sogoucdn.com/app/a/200698/sogou_science_4345","rw":300,"rh":300,"title":"奎宁水，在正常光线和紫外线“黑光”照射下。奎宁水的奎宁含量使其在黑光下发出荧光。","alt":null,"width":0,"height":0},{"originalUrl":"https://web.archive.org/web/20221028211208/https://img04.sogoucdn.com/app/a/200698/sogou_science_4346?h=200&titlename=R.B%20.%E4%BC%8D%E5%BE%B7%E6%B2%83%E5%BE%B7&w=300","url":"https://web.archive.org/web/20221028211208/https://img04.sogoucdn.com/app/a/200698/sogou_science_4346","rw":300,"rh":200,"title":"R.B .伍德沃德","alt":null,"width":0,"height":0},{"originalUrl":"https://web.archive.org/web/20221028211208/https://img02.sogoucdn.com/app/a/200698/sogou_science_10696?w=300&h=368&titlename=%E5%A5%8E%E5%AE%81%E7%9A%84%E7%94%9F%E7%89%A9%E5%90%88%E6%88%90","url":"https://web.archive.org/web/20221028211208/https://img02.sogoucdn.com/app/a/200698/sogou_science_10696","rw":300,"rh":368,"title":"奎宁的生物合成","alt":null,"width":0,"height":0},{"originalUrl":"https://web.archive.org/web/20221028211208/https://img01.sogoucdn.com/app/a/200698/sogou_science_4347?w=300&h=421&titlename=19%E4%B8%96%E7%BA%AA%E9%87%91%E9%B8%A1%E7%BA%B3%E6%A0%91%E7%9A%84%E6%8F%92%E5%9B%BE","url":"https://web.archive.org/web/20221028211208/https://img01.sogoucdn.com/app/a/200698/sogou_science_4347","rw":300,"rh":421,"title":"19世纪金鸡纳树的插图","alt":null,"width":0,"height":0}],"catalogs":[{"level":1,"title":"用途","paragraphId":"14994006563881480","subCatalogs":[{"level":2,"title":"医疗","paragraphId":"14994006563881480","subCatalogs":null},{"level":2,"title":"饮料","paragraphId":"14994006563881480","subCatalogs":null},{"level":2,"title":"科学用途","paragraphId":"14994006563881480","subCatalogs":null}]},{"level":1,"title":"禁忌症","paragraphId":"14994006563881481","subCatalogs":null},{"level":1,"title":"不良影响","paragraphId":"14994006580658691","subCatalogs":null},{"level":1,"title":"作用机理","paragraphId":"14994006580658692","subCatalogs":null},{"level":1,"title":"化学","paragraphId":"14994006580658693","subCatalogs":[{"level":2,"title":"合成","paragraphId":"14994006580658693","subCatalogs":null}]},{"level":1,"title":"生物合成","paragraphId":"14994006580658694","subCatalogs":null},{"level":1,"title":"自然发生","paragraphId":"14994006580658695","subCatalogs":null},{"level":1,"title":"历史","paragraphId":"14994006597435916","subCatalogs":null},{"level":1,"title":"社会和文化","paragraphId":"14994006597435917","subCatalogs":[{"level":2,"title":"管理","paragraphId":"14994006597435917","subCatalogs":null},{"level":2,"title":"切割剂","paragraphId":"14994006597435917","subCatalogs":null}]},{"level":1,"title":"其他动物","paragraphId":"14994006597435918","subCatalogs":null},{"level":1,"title":"参考文献","paragraphId":"-1","subCatalogs":null}],"paragraphs":[{"paragraphId":"14994006563881480","title":"用途","versionId":"52066609333848335","lemmaId":10014,"createType":0,"creator":{"uid":0,"name":null,"pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"createTime":0,"versionEditor":{"uid":81910391,"name":"哈哈","pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"editTime":1598330117,"comment":null,"dependVersionId":0,"contentType":1,"content":"<p></p><h3>医疗</h3><p></p><p>自2006年起，世卫组织(世界卫生组织)不再建议将其作为疟疾的一线治疗方法，仅在青蒿素不可用时使用。<sup><a href=\"#quote_10\" class=\"kx_ref\">[10]</a></sup><sup><a href=\"#quote_11\" class=\"kx_ref\">[11]</a></sup><sup><a href=\"#quote_12\" class=\"kx_ref\">[12]</a></sup><sup><a href=\"#quote_13\" class=\"kx_ref\">[13]</a></sup>奎宁也用于治疗狼疮和关节炎。</p><p>在过去，奎宁经常被作为治疗夜间腿部抽筋的非标签药物，但由于食品和药物管理局警告称这种做法可能会导致危及生命的副作用，这种情况变得不那么常见了。<sup><a href=\"#quote_14\" class=\"kx_ref\">[14]</a></sup> </p><p><strong>可用形式</strong></p><p>奎宁是一种碱性胺，通常以盐的形式存在。现有的各种制剂包括盐酸盐、二盐酸盐、硫酸盐、硫酸氢盐和葡萄糖酸盐。在美国，硫酸奎宁在市场上以324毫克片剂的形式出售，品牌为Qualaquin。</p><p>所有奎宁盐可以口服或静脉注射(四)；葡萄糖酸奎宁也可以肌肉注射或直肠注射。<sup><a href=\"#quote_15\" class=\"kx_ref\">[15]</a></sup><sup><a href=\"#quote_16\" class=\"kx_ref\">[16]</a></sup>直肠注射的主要问题是剂量在被完全吸收之前就会被排出体外；临床中，这可以通过再给一半剂量来弥补。奎宁注射制剂在美国没有被许可使用；取而代之的是奎尼丁。<sup><a href=\"#quote_17\" class=\"kx_ref\">[17]</a></sup><sup><a href=\"#quote_18\" class=\"kx_ref\">[18]</a></sup> </p><p>\n </p><table class=\"wikitable\">\n  <caption>\n   <b>各种盐中奎宁碱含量</b> \n  </caption>\n  <tbody>\n   <tr>\n    <th>姓名</th>\n    <th>奎宁碱当量</th>\n   </tr>\n   <tr>\n    <td>奎宁碱</td>\n    <td>100毫克</td>\n   </tr>\n   <tr>\n    <td>硫酸奎宁</td>\n    <td>169毫克</td>\n   </tr>\n   <tr>\n    <td>盐酸奎宁</td>\n    <td>122毫克</td>\n   </tr>\n   <tr>\n    <td>葡萄糖酸奎宁</td>\n    <td>160毫克</td>\n   </tr>\n   <tr>\n    <td>盐酸奎宁</td>\n    <td>111毫克</td>\n   </tr>\n   <tr>\n    <td>硫酸奎宁二水合物</td>\n    <td>121毫克</td>\n   </tr>\n  </tbody>\n </table><p></p><p></p><h3>饮料</h3><p></p><p><img alt=\"\" class=\"fileimage kx_img ed_imgfloat_right\" img_height=\"300\" img_width=\"300\" titlename=\"奎宁水，在正常光线和紫外线“黑光”照射下。奎宁水的奎宁含量使其在黑光下发出荧光。\" data-src=\"https://img01.sogoucdn.com/app/a/200698/sogou_science_4345\"> </p><p>奎宁是汤力水和苦味柠檬混合饮料的风味成分。在许多酒吧后的苏打枪上，奎宁水由代表奎宁的字母“Q”表示。<sup><a href=\"#quote_19\" class=\"kx_ref\">[19]</a></sup> </p><p>根据传统，抗疟药奎宁汤剂的苦味导致在印度的英国殖民者将其与杜松子酒混合，从而创造出至今仍受欢迎的标志性杜松子奎宁鸡尾酒。如今，奎宁补剂中奎宁的含量要低得多，饮用它来治疗疟疾是没有用的。在美国，奎宁被列为一些调味Snapple饮料 (包括蔓越莓-覆盆子口味)的一种成分。</p><p>在法国，奎宁是一种叫做quinquina或\"Cap Corse\"的开胃酒和一种以葡萄酒为基础的开胃杜本内酒的成分。在西班牙，奎宁(“秘鲁树皮”)有时被混入甜马拉加酒，然后被称为“Malaga Quina”。在意大利，传统风味葡萄酒Barolo Chinato被注入奎宁和当地草药，并被用作餐后酒。在加拿大和意大利，奎宁是碳酸圣培露果汁饮料Brio和San Pellegrino的一种成分。在苏格兰，A.G. Barr公司使用奎宁作为碳酸饮料和含咖啡因饮料Irn-Bru的成分。在乌拉圭和阿根廷，奎宁是百事可乐公司汤力水的一种成分。在丹麦，它被用作Royal Unibrew公司生产的碳酸运动饮料Faxe Kondi的成分。</p><p>作为饮料中的调味剂，奎宁含量在美国被限制在百万分之83以下，在欧盟被限制在百万分之100毫克。<sup><a href=\"#quote_20\" class=\"kx_ref\">[20]</a></sup><sup><a href=\"#quote_21\" class=\"kx_ref\">[21]</a></sup><sup><a href=\"#quote_22\" class=\"kx_ref\">[22]</a></sup> </p><p></p><h3>科学用途</h3><p></p><p>奎宁(和奎尼丁)被用作手性配体，用于Sharpless不对称二羟基化中，也是许多其他手性催化剂的骨架。奎宁由于其众所周知且相对恒定的荧光量子产率，在光化学中被用作常见的荧光标准物质。 </p>","pics":[{"originalUrl":"https://web.archive.org/web/20221028211208/https://img01.sogoucdn.com/app/a/200698/sogou_science_4345?w=300&h=300&titlename=%E5%A5%8E%E5%AE%81%E6%B0%B4%EF%BC%8C%E5%9C%A8%E6%AD%A3%E5%B8%B8%E5%85%89%E7%BA%BF%E5%92%8C%E7%B4%AB%E5%A4%96%E7%BA%BF%E2%80%9C%E9%BB%91%E5%85%89%E2%80%9D%E7%85%A7%E5%B0%84%E4%B8%8B%E3%80%82%E5%A5%8E%E5%AE%81%E6%B0%B4%E7%9A%84%E5%A5%8E%E5%AE%81%E5%90%AB%E9%87%8F%E4%BD%BF%E5%85%B6%E5%9C%A8%E9%BB%91%E5%85%89%E4%B8%8B%E5%8F%91%E5%87%BA%E8%8D%A7%E5%85%89%E3%80%82","url":"https://web.archive.org/web/20221028211208/https://img01.sogoucdn.com/app/a/200698/sogou_science_4345","rw":300,"rh":300,"title":"奎宁水，在正常光线和紫外线“黑光”照射下。奎宁水的奎宁含量使其在黑光下发出荧光。","alt":null,"width":0,"height":0}],"card":null,"references":[],"versionCount":0},{"paragraphId":"14994006563881481","title":"禁忌症","versionId":"52066609333848336","lemmaId":10014,"createType":0,"creator":{"uid":0,"name":null,"pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"createTime":0,"versionEditor":{"uid":81910391,"name":"哈哈","pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"editTime":1598330117,"comment":null,"dependVersionId":0,"contentType":1,"content":"<p>由于奎宁的治疗作用和毒性作用差别很小，因此奎宁是药物性疾病的常见原因，包括血小板减少症和血栓性微血管病。 即使普通饮料中含有少量奎宁，奎宁也可能对多器官系统产生严重的副作用，其中包括免疫系统效应和发烧、低血压、溶血性贫血、急性肾损伤、肝毒性和失明。 对于患有心房颤动、传导缺陷或心脏传导阻滞的患者，奎宁可导致心律失常，应避免摄入。</p><p>奎宁可导致G6PD缺乏症(一种遗传性缺陷)的溶血，但这种风险很小，当别无选择时，医生应该毫不犹豫地对UIG6PD缺乏症患者使用奎宁。 </p>","pics":null,"card":null,"references":[],"versionCount":0},{"paragraphId":"14994006580658691","title":"不良影响","versionId":"52066609333848337","lemmaId":10014,"createType":0,"creator":{"uid":0,"name":null,"pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"createTime":0,"versionEditor":{"uid":81910391,"name":"哈哈","pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"editTime":1598330117,"comment":null,"dependVersionId":0,"contentType":1,"content":"<p>奎宁可导致不可预测且严重危及生命的血液和心血管反应，包括血小板计数低和溶血性尿毒症综合征/血栓性血小板减少性紫癜(HUS/TTP)、长QT综合征和其他严重心律失常，包括尖端扭转型室性心动过速、黑水热、弥散性血管内凝血、白细胞减少和中性粒细胞减少。一些由于奎宁而发展成TTP的人，后来发展成肾衰竭。<sup><a href=\"#quote_23\" class=\"kx_ref\">[23]</a></sup> 它还可引起严重过敏反应，包括过敏性休克、荨麻疹、严重皮疹(包括史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症)、血管性水肿、面部水肿、支气管痉挛、肉芽肿性肝炎和瘙痒。<sup><a href=\"#quote_23\" class=\"kx_ref\">[23]</a></sup> </p><p>最常见的副作用包括一组称为金鸡纳病的症状，包括头痛、血管扩张和出汗、恶心、耳鸣、听力损伤、眩晕或头晕、视力模糊和色觉障碍。<sup><a href=\"#quote_23\" class=\"kx_ref\">[23]</a></sup><sup><a href=\"#quote_23\" class=\"kx_ref\">[23]</a></sup> 更严重的金鸡纳病包括呕吐、腹泻、腹痛、耳聋、失明和心律失常。<sup><a href=\"#quote_23\" class=\"kx_ref\">[23]</a></sup> 当口服奎宁时，金鸡纳病不太常见，但口服奎宁耐受性不好(奎宁非常苦，许多患者在服用奎宁片后会呕吐):当需要口服治疗时，通常会使用其他药物，如西达 (磺胺多辛和乙胺嘧啶)或马拉酮(丙胍和阿托瓦酮)。碳酸奎宁乙酯无臭无味，<sup><a href=\"#quote_23\" class=\"kx_ref\">[23]</a></sup> 但仅在日本有售。口服奎宁时，不需要血糖、电解质和心脏监测。</p>","pics":null,"card":null,"references":[],"versionCount":0},{"paragraphId":"14994006580658692","title":"作用机理","versionId":"52066609333848338","lemmaId":10014,"createType":0,"creator":{"uid":0,"name":null,"pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"createTime":0,"versionEditor":{"uid":81910391,"name":"哈哈","pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"editTime":1598330117,"comment":null,"dependVersionId":0,"contentType":1,"content":"<p>奎宁通过干扰疟原虫溶解和代谢血红蛋白的能力，被认为对疟疾病原体恶性疟原虫有毒性。<sup><a href=\"#quote_24\" class=\"kx_ref\">[24]</a></sup>与其他喹啉抗疟药一样，奎宁的作用机制尚未完全阐明。对其作用最广泛接受的假设是基于研究充分且密切相关的喹啉药物氯喹。该模型包括抑制血红素解毒途径中的疟原虫色素生物结晶，从而促进细胞毒性血红素的聚集。游离细胞毒性血红素在寄生虫中积累，可导致它们死亡。<sup><a href=\"#quote_25\" class=\"kx_ref\">[25]</a></sup>奎宁可能靶向疟疾的嘌呤核苷磷酸化酶。<sup><a href=\"#quote_26\" class=\"kx_ref\">[26]</a></sup> </p>","pics":null,"card":null,"references":[],"versionCount":0},{"paragraphId":"14994006580658693","title":"化学","versionId":"52066609333848339","lemmaId":10014,"createType":0,"creator":{"uid":0,"name":null,"pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"createTime":0,"versionEditor":{"uid":81910391,"name":"哈哈","pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"editTime":1598330117,"comment":null,"dependVersionId":0,"contentType":1,"content":"<p><img alt=\"\" class=\"fileimage kx_img ed_imgfloat_right\" img_height=\"200\" img_width=\"300\" titlename=\"R.B .伍德沃德\" data-src=\"https://img04.sogoucdn.com/app/a/200698/sogou_science_4346\"> </p><p>奎宁的紫外吸收峰值约在350纳米(长波紫外线)。荧光发射峰值约在460纳米(亮蓝色/青色)。<sup><a href=\"#quote_27\" class=\"kx_ref\">[27]</a></sup>奎宁在0.1 M硫酸溶液中具有高荧光性(量子产率约为0.58)。<sup><a href=\"#quote_28\" class=\"kx_ref\">[28]</a></sup><sup><a href=\"#quote_28\" class=\"kx_ref\">[28]</a></sup> </p><p></p><h3>合成</h3><p></p><p>金鸡纳树仍然是奎宁唯一经济实用的的来源。然而，在战时压力下，有许多科学家对奎宁的合成生产进行了研究。美国化学家伍德沃德和多灵于1944年完成了正式的奎宁化学合成。<sup><a href=\"#quote_28\" class=\"kx_ref\">[28]</a></sup>自那以后，已经实现了几种更高效的奎宁全合成方法，<sup><a href=\"#quote_29\" class=\"kx_ref\">[29]</a></sup>但是没有一种能在经济方面与从天然来源中分离奎宁相媲美。1856年，威廉·亨利·珀金在试图合成奎宁时发现了第一种合成有机染料苯胺紫。</p>","pics":[{"originalUrl":"https://web.archive.org/web/20221028211208/https://img04.sogoucdn.com/app/a/200698/sogou_science_4346?h=200&titlename=R.B%20.%E4%BC%8D%E5%BE%B7%E6%B2%83%E5%BE%B7&w=300","url":"https://web.archive.org/web/20221028211208/https://img04.sogoucdn.com/app/a/200698/sogou_science_4346","rw":300,"rh":200,"title":"R.B .伍德沃德","alt":null,"width":0,"height":0}],"card":null,"references":[],"versionCount":0},{"paragraphId":"14994006580658694","title":"生物合成","versionId":"52066609333848340","lemmaId":10014,"createType":0,"creator":{"uid":0,"name":null,"pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"createTime":0,"versionEditor":{"uid":81910391,"name":"哈哈","pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"editTime":1598330117,"comment":null,"dependVersionId":0,"contentType":1,"content":"<p><img alt=\"\" class=\"fileimage kx_img ed_imgfloat_right\" img_height=\"368\" img_width=\"300\" titlename=\"奎宁的生物合成\" data-src=\"https://img02.sogoucdn.com/app/a/200698/sogou_science_10696\"> </p><p>在奎宁生物合成的第一步中，异胡豆苷合成酶催化色胺tryptamine与secologanin之间的立体选择性Pictet-Spengler反应以产生异胡豆苷。 <sup><a href=\"#quote_30\" class=\"kx_ref\">[30]</a></sup><sup><a href=\"#quote_31\" class=\"kx_ref\">[31]</a></sup> 适当的修饰异胡豆苷可得到醛。水解和脱羧最初将从环烯醚萜部分除去一个碳并产生棒状鞘。然后将色胺侧链在氮附近裂解，再将该氮键与乙醛官能团结合，得到辛可卡因cinchonaminal。吲哚杂环中的开环可以产生新的胺和酮官能团。然后，通过将该胺与色胺侧链裂解中产生的醛组合，形成新的喹啉杂环，得到辛可尼酮cinchonidinone。最后一步，羟基化和甲基化得到奎宁。<sup><a href=\"#quote_32\" class=\"kx_ref\">[32]</a></sup><sup><a href=\"#quote_33\" class=\"kx_ref\">[33]</a></sup> </p>","pics":[{"originalUrl":"https://web.archive.org/web/20221028211208/https://img02.sogoucdn.com/app/a/200698/sogou_science_10696?w=300&h=368&titlename=%E5%A5%8E%E5%AE%81%E7%9A%84%E7%94%9F%E7%89%A9%E5%90%88%E6%88%90","url":"https://web.archive.org/web/20221028211208/https://img02.sogoucdn.com/app/a/200698/sogou_science_10696","rw":300,"rh":368,"title":"奎宁的生物合成","alt":null,"width":0,"height":0}],"card":null,"references":[],"versionCount":0},{"paragraphId":"14994006580658695","title":"自然发生","versionId":"52066609333848341","lemmaId":10014,"createType":0,"creator":{"uid":0,"name":null,"pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"createTime":0,"versionEditor":{"uid":81910391,"name":"哈哈","pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"editTime":1598330117,"comment":null,"dependVersionId":0,"contentType":1,"content":"<p>自然来源铜色树树皮含有0.5-2%的奎宁。它的树皮比金鸡纳树皮便宜。因为它有强烈的味道，所以被用来制作汤力水。<sup><a href=\"#quote_34\" class=\"kx_ref\">[34]</a></sup> </p>","pics":null,"card":null,"references":[],"versionCount":0},{"paragraphId":"14994006597435916","title":"历史","versionId":"52066609333848342","lemmaId":10014,"createType":0,"creator":{"uid":0,"name":null,"pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"createTime":0,"versionEditor":{"uid":81910391,"name":"哈哈","pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"editTime":1598330117,"comment":null,"dependVersionId":0,"contentType":1,"content":"<p><img alt=\"\" class=\"fileimage kx_img ed_imgfloat_right\" img_height=\"421\" img_width=\"300\" titlename=\"19世纪金鸡纳树的插图\" data-src=\"https://img01.sogoucdn.com/app/a/200698/sogou_science_4347\"> </p><p>奎宁也是第一种用于治疗疟疾的药物。<sup><a href=\"#quote_35\" class=\"kx_ref\">[35]</a></sup> 奎宁被秘鲁、玻利维亚和厄瓜多尔土著奎丘亚人用作肌肉松弛剂，以治疗因低温而引起的颤抖。<sup><a href=\"#quote_36\" class=\"kx_ref\">[36]</a></sup> 奎丘亚人会将金鸡纳树的树皮与甜味水混合，以抵消树皮的苦味，从而制作汤力水。</p><p>耶稣会士是第一个把金鸡纳带到欧洲的人。西班牙人在17世纪70年代或更早就知道金鸡纳树皮的药用价值:尼古拉斯·莫纳德斯(1571)和胡安·弗拉戈索(1572)都描述了一种后来被确定为金鸡纳树的树，其树皮被用来生产治疗腹泻的饮料。<sup><a href=\"#quote_37\" class=\"kx_ref\">[37]</a></sup> 奎宁至少从17世纪早期开始就被欧洲人以未提纯的形式使用。1631年，它首次在罗马被用于治疗疟疾。在17世纪，疟疾是罗马城周围沼泽和湿地的地方病。疟疾导致了几位教皇、许多红衣主教和无数普通罗马公民的死亡。在罗马接受训练的大多数牧师都见过疟疾患者，并且熟悉该疾病发热阶段颤抖的症状。<sup><a href=\"#quote_38\" class=\"kx_ref\">[38]</a></sup> 一个住在利马接受训练的药剂师，耶稣会修士阿戈斯蒂诺·萨伦比诺(1564-1642)，观察到奎丘亚人使用金鸡纳树的树皮来达到治疗疟疾的目的。虽然它在治疗疟疾(以及疟疾引起的颤抖)方面的效果与它在治疗寒颤的效果无关，但它是一种成功的抗疟疾药物。很快，萨伦比诺就派了少量人员到罗马进行疟疾治疗试验。<sup><a href=\"#quote_39\" class=\"kx_ref\">[39]</a></sup> 在接下来的几年里，金鸡纳树皮，被称为耶稣会树皮或秘鲁树皮，成为从秘鲁运往欧洲的最有价值的商品之一。当查理二世国王在17世纪末用奎宁治愈疟疾时，它在伦敦开始流行起来。<sup><a href=\"#quote_40\" class=\"kx_ref\">[40]</a></sup>在20世纪40年代其他药物取代它之前，它一直是首选的抗疟药。<sup><a href=\"#quote_41\" class=\"kx_ref\">[41]</a></sup> </p><p>查理·玛丽·德·拉·孔达明在1737年发现了治疗疟疾最有效的奎宁。<sup><a href=\"#quote_42\" class=\"kx_ref\">[42]</a></sup><sup><a href=\"#quote_43\" class=\"kx_ref\">[43]</a></sup>1820年，法国研究人员皮埃尔·约瑟夫·佩尔蒂埃和约瑟夫·别奈姆·卡旺图首先从金鸡纳属的树皮中分离出奎宁，并随后用金鸡纳命名了这种物质。<sup><a href=\"#quote_44\" class=\"kx_ref\">[44]</a></sup>这个名字来源于金鸡纳树皮的最初的盖丘亚(印加)单词，quina或quinaquina, 意思是“树皮的树皮”或“神圣的树皮”。在1820年之前，树皮首先被干燥，磨成细粉，然后混合成液体(通常是葡萄酒)，然后被饮用。奎宁作为疟疾预防药物的大规模使用始于1850年左右。1853年，保罗·布利特出版了《奎那》的简史和文献讨论。<sup><a href=\"#quote_45\" class=\"kx_ref\">[45]</a></sup> </p><p>奎宁在欧洲人对非洲的殖民统治中发挥了重要作用。奎宁被认为是非洲不再被称为“白人坟墓”的主要原因。一位历史学家曾说过，“奎宁的功效给了殖民者涌入黄金海岸、尼日利亚和西非其他地区的新机会”。<sup><a href=\"#quote_46\" class=\"kx_ref\">[46]</a></sup> </p><p>为了保持对金鸡纳树皮的垄断，秘鲁及其周边国家在19世纪初开始禁止金鸡纳种子和树苗的出口。荷兰政府仍然持续走私奎宁种子，在19世纪晚期，荷兰人在印度尼西亚种植园种植这种植物。很快他们成为了工厂的主要供应商，并在1913年成立了Kina Bureau，一个金鸡纳生产卡特尔（垄断集团），负责控制价格和生产。<sup><a href=\"#quote_47\" class=\"kx_ref\">[47]</a></sup>到20世纪30年代，爪哇的荷兰种植园生产了2200万磅金鸡纳树皮，占世界奎宁产量的97%。<sup><a href=\"#quote_46\" class=\"kx_ref\">[46]</a></sup>美国尝试起诉Kina Bureau，但是没有成功。<sup><a href=\"#quote_47\" class=\"kx_ref\">[47]</a></sup>第二次世界大战期间，德国占领荷兰，日本在控制菲律宾和印度尼西亚的同时，切断了同盟国奎宁的供应。美国从菲律宾获得了400万颗金鸡纳种子，并开始在哥斯达黎加经营金鸡纳种植园。但这些物资来得太晚了，成千上万的美国驻非洲和南太平洋部队因缺乏奎宁而死亡。<sup><a href=\"#quote_46\" class=\"kx_ref\">[46]</a></sup>尽管控制了奎宁的供应，日本人并没有有效利用奎宁，结果成千上万的日本军队在西南太平洋阵亡。<sup><a href=\"#quote_48\" class=\"kx_ref\">[48]</a></sup><sup><a href=\"#quote_49\" class=\"kx_ref\">[49]</a></sup><sup><a href=\"#quote_50\" class=\"kx_ref\">[50]</a></sup><sup><a href=\"#quote_51\" class=\"kx_ref\">[51]</a></sup>奎宁一直是抗疟疾的首选药物，直到二战后，其他副作用较少的药物，如氯喹，基本上取代了奎宁。<sup><a href=\"#quote_52\" class=\"kx_ref\">[52]</a></sup> </p><p>Bromo Quinine是格罗夫实验室生产的含有奎宁的品牌感冒药。它们第一次上市是在1889年，但至少在20世纪60年代才能买到。<sup><a href=\"#quote_53\" class=\"kx_ref\">[53]</a></sup> </p>","pics":[{"originalUrl":"https://web.archive.org/web/20221028211208/https://img01.sogoucdn.com/app/a/200698/sogou_science_4347?w=300&h=421&titlename=19%E4%B8%96%E7%BA%AA%E9%87%91%E9%B8%A1%E7%BA%B3%E6%A0%91%E7%9A%84%E6%8F%92%E5%9B%BE","url":"https://web.archive.org/web/20221028211208/https://img01.sogoucdn.com/app/a/200698/sogou_science_4347","rw":300,"rh":421,"title":"19世纪金鸡纳树的插图","alt":null,"width":0,"height":0}],"card":null,"references":[],"versionCount":0},{"paragraphId":"14994006597435917","title":"社会和文化","versionId":"52066609333848343","lemmaId":10014,"createType":0,"creator":{"uid":0,"name":null,"pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"createTime":0,"versionEditor":{"uid":81910391,"name":"哈哈","pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"editTime":1598330117,"comment":null,"dependVersionId":0,"contentType":1,"content":"<p><h3>管理</h3></p><p>从1969年到1992年，美国食品和药物管理局(FDA)收到了157份与奎宁使用有关的健康问题报告，其中包括23份导致死亡的报告。<sup><a href=\"#quote_54\" class=\"kx_ref\">[54]</a></sup>1994年，美国食品和药物管理局禁止销售非处方药奎宁来治疗夜间腿部痉挛。为此，辉瑞制药一直在出售品牌为Legatrin的药品。也作为软胶囊出售(由史密斯公司出品)。医生仍可能开含奎宁的处方，但是食品和药物管理局已经命令公司停止销售未经批准的含奎宁的药品。美国食品和药物管理局也警告消费者在使用非标签奎宁药品治疗腿部痉挛需谨慎。奎宁被批准用于治疗疟疾，但也常用于治疗腿部痉挛和类似疾病。因为疟疾威胁生命，使用奎宁治疗这种疾病的风险被认为是可以接受的。<sup><a href=\"#quote_55\" class=\"kx_ref\">[55]</a></sup> </p><p>虽然Legatrin被美国食品和药物管理局禁止用于治疗腿部痉挛，但药品制造商URL Mutual已经给一种含有奎宁的药物命名为Qualaquin。它作为治疗疟疾的药物在市场上销售，在美国只能通过处方购买。2004年，美国疾病预防控制中心仅报告了1347例确诊疟疾病例。<sup><a href=\"#quote_56\" class=\"kx_ref\">[56]</a></sup> </p><p><h3>切割剂</h3></p><p>奎宁有时被发现用于可卡因和海洛因等街头毒品的切割剂。<sup><a href=\"#quote_57\" class=\"kx_ref\">[57]</a></sup> </p>","pics":null,"card":null,"references":[],"versionCount":0},{"paragraphId":"14994006597435918","title":"其他动物","versionId":"52066609333848344","lemmaId":10014,"createType":0,"creator":{"uid":0,"name":null,"pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"createTime":0,"versionEditor":{"uid":81910391,"name":"哈哈","pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"editTime":1598330117,"comment":null,"dependVersionId":0,"contentType":1,"content":"<p>奎宁用于治疗海洋观赏鱼的刺激隐核虫(通常称为白斑、隐核或白点病)感染。<sup><a href=\"#quote_58\" class=\"kx_ref\">[58]</a></sup> </p>","pics":null,"card":null,"references":[],"versionCount":0}],"references":[{"id":1,"type":"book","title":"\"Quinine Sulfate\". The American Society of Health-System Pharmacists. Archived from the original on 5 December 2015. Retrieved 2 November 2017.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":2,"type":"book","title":"Esu E, Effa EE, Opie ON, Uwaoma A, Meremikwu MM (September 2014). \"Artemether for severe malaria\". The Cochrane Database of Systematic Reviews. 9 (9): CD010678. doi:10.1002/14651858.CD010678.pub2. PMC 4455227. PMID 25209020.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":3,"type":"book","title":"Olmsted J, Williams GM (1997). Chemistry: The Molecular Science (in 英语). Jones & Bartlett Learning. p. 137. ISBN 978-0-815-18450-8. Archived from the original on 15 September 2016.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":4,"type":"book","title":"Willcox M (28 June 2004). Traditional Medicinal Plants and Malaria. CRC Press. p. 231. ISBN 9780203502327.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":5,"type":"book","title":"Cechinel-Filho V (2012). Plant bioactives and drug discovery : principles, practice, and perspectives. Hoboken, N.J.: John Wiley & Sons. p. 2. ISBN 9780470582268. Archived from the original on 4 March 2016.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":6,"type":"book","title":"Staines HM, Krishna S (2011). Treatment and Prevention of Malaria : Antimalarial Drug Chemistry, Action and Use. [S.l.]: Springer Verlag. p. 45. ISBN 9783034604796.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":7,"type":"book","title":"\"WHO Model List of Essential Medicines (19th List)\" (PDF). World Health Organization. April 2015. Archived (PDF) from the original on 13 December 2016. Retrieved 8 December 2016.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":8,"type":"book","title":"\"Quinine Sulfate\". International Drug Price Indicator Guide. Retrieved 12 January 2016.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":9,"type":"book","title":"Hamilton R (2015). Tarascon Pocket Pharmacopoeia 2015 Deluxe Lab-Coat Edition. Jones & Bartlett Learning. p. 47. ISBN 9781284057560.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":10,"type":"book","title":"Achan J, Tibenderana JK, Kyabayinze D, Wabwire Mangen F, Kamya MR, Dorsey G, D'Alessandro U, Rosenthal PJ, Talisuna AO (July 2009). \"Effectiveness of quinine versus artemether-lumefantrine for treating uncomplicated falciparum malaria in Ugandan children: randomised trial\". Bmj. 339: b2763. doi:10.1136/bmj.b2763. PMC 2714631. PMID 19622553.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":11,"type":"book","title":"World Health Organization (2006). \"Guidelines for the treatment of malaria\" (PDF). World Health Organization. Archived (PDF) from the original on 5 August 2009. Retrieved 10 August 2009.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":12,"type":"book","title":"Dondorp A, Nosten F, Stepniewska K, Day N, White N (2005). \"Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial\". Lancet. 366 (9487): 717–25. doi:10.1016/S0140-6736(05)67176-0. PMID 16125588.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":13,"type":"book","title":"Reyburn H, Mtove G, Hendriksen I, von Seidlein L (July 2009). \"Oral quinine for the treatment of uncomplicated malaria\" (PDF). Bmj. 339: b2066. doi:10.1136/bmj.b2066. PMID 19622550.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":14,"type":"book","title":"\"FDA Drug Safety Communication: New risk management plan and patient Medication Guide for Qualaquin (quinine sulfate)\". Food and Drug Administration. 7 August 2010. Archived from the original on 19 February 2011. Retrieved 21 February 2011.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":15,"type":"book","title":"Barennes H, Pussard E, Mahaman Sani A, Clavier F, Kahiatani F, Granic G, Henzel D, Ravinet L, Verdier F (May 1996). \"Efficacy and pharmacokinetics of a new intrarectal quinine formulation in children with Plasmodium falciparum malaria\". British Journal of Clinical Pharmacology. 41 (5): 389–95. doi:10.1046/j.1365-2125.1996.03246.x. PMC 2042609. PMID 8735679.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":16,"type":"book","title":"Barennes H, Balima-Koussoubé T, Nagot N, Charpentier JC, Pussard E (May 2006). \"Safety and efficacy of rectal compared with intramuscular quinine for the early treatment of moderately severe malaria in children: randomised clinical trial\". Bmj. 332 (7549): 1055–9. doi:10.1136/bmj.332.7549.1055. PMC 1458599. PMID 16675812.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":17,"type":"book","title":"Centers for Disease Control and Prevention (April 1991). \"Treatment with quinidine gluconate of persons with severe Plasmodium falciparum infection: discontinuation of parenteral quinine from CDC Drug Service\". MMWR. Recommendations and Reports. 40 (RR-4): 21–3. PMID 1850497.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":18,"type":"book","title":"Magill A, Panosian C (July 2005). \"Making antimalarial agents available in the United States\". The New England Journal of Medicine. 353 (4): 335–7. doi:10.1056/NEJMp058167. PMID 16000347.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":19,"type":"book","title":"Charming C (2006). Miss Charming's Guide for Hip Bartenders and Wayout Wannabes. USA: Sourcebooks, Inc. p. 189. ISBN 978-1-4022-0804-1.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":20,"type":"book","title":"Ballestero JA, Plazas PV, Kracun S, Gómez-Casati ME, Taranda J, Rothlin CV, Katz E, Millar NS, et al. (September 2005). \"Effects of quinine, quinidine, and chloroquine on alpha9alpha10 nicotinic cholinergic receptors\". Molecular Pharmacology. 68 (3): 822–9. doi:10.1124/mol.105.014431. PMID 15955868.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":21,"type":"book","title":"\"Food Additive Status List\". U.S. Food and Drug Administration. U.S. Department of Health and Human Services. Retrieved 9 October 2017.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":22,"type":"book","title":"\"COMMISSION IMPLEMENTING REGULATION (EU) No 872/2012\". EUR-Lex. Official Journal of the European Union. Retrieved 9 October 2017.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":23,"type":"book","title":"Liles NW, Page EE, Liles AL, Vesely SK, Raskob GE, George JN (May 2016). \"Diversity and severity of adverse reactions to quinine: A systematic review\". American Journal of Hematology. 91 (5): 461–6. doi:10.1002/ajh.24314. PMID 26822544.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":24,"type":"book","title":"DrugBank, ed. (24 February 2017). \"Quinine\". DrugBank. Archived from the original on 6 February 2017.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":25,"type":"book","title":"Foley M, Tilley L (February 1997). \"Quinoline antimalarials: mechanisms of action and resistance\". International Journal for Parasitology. 27 (2): 231–40. doi:10.1016/s0020-7519(96)00152-x. PMID 9088993.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":26,"type":"book","title":"Lowe D (22 January 2019). \"Quinine's Target\". Science. Retrieved 28 January 2019.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":27,"type":"book","title":"\"Basic Concepts in Fluorescence\". Archived from the original on 13 September 2012.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":28,"type":"book","title":"Joseph R. Lakowicz. Principles of Fluorescence Spectroscopy Archived 1 8月 2016 at the Wayback Machine 3rd edition. Springer (2006). ISBN 978-0387-31278-1. Chapter 2. page 54.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":29,"type":"book","title":"Kaufman TS, Rúveda EA (2005). \"Die Jagd auf Chinin: Etappenerfolge und Gesamtsiege\". Angewandte Chemie International Edition (in 德语). 117 (6): 876–907. doi:10.1002/ange.200400663.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":30,"type":"book","title":"Treimer JF, Zenk MH (November 1979). \"Purification and properties of strictosidine synthase, the key enzyme in indole alkaloid formation\". European Journal of Biochemistry. 101 (1): 225–33. doi:10.1111/j.1432-1033.1979.tb04235.x. PMID 510306.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":31,"type":"book","title":"Mizukami H, Nordlöv H, Lee SL, Scott AI (August 1979). \"Purification and properties of strictosidine synthetase (an enzyme condensing tryptamine and secologanin) from Catharanthus roseus cultured cells\". Biochemistry. 18 (17): 3760–3. doi:10.1021/bi00584a018. PMID 476085.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":32,"type":"book","title":"Medicinal natural products : a biosynthetic approach (3rdition ed.). Wiley. pp. 380–381. ISBN 9780470742761.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":33,"type":"book","title":"O'Connor SE, Maresh JJ (August 2006). \"Chemistry and biology of monoterpene indole alkaloid biosynthesis\". Natural Product Reports. 23 (4): 532–47. doi:10.1039/b512615k. PMID 16874388.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":34,"type":"book","title":"Hobhouse H (2004). Šest rostlin, které změnily svět (in Czech). Prague: Akademie věd České republiky. p. 59. ISBN 978-80-200-1179-4.CS1 maint: Unrecognized language (link)","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":35,"type":"book","title":"Achan J, Talisuna AO, Erhart A, Yeka A, Tibenderana JK, Baliraine FN, Rosenthal PJ, D'Alessandro U (May 2011). \"Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria\". Malaria Journal. 10: 144. doi:10.1186/1475-2875-10-144. PMC 3121651. PMID 21609473.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":36,"type":"book","title":"History of quinine: Friedrich A. Flückiger and Daniel Hanbury, Pharmacographia: A history of the principal drugs of vegetable origin, met with in Great Britain and British India (London, England: Macmillan and Co., 1874), pages 302-331: Cortex Cinchonæ Archived 11 11月 2014 at the Wayback Machine.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":37,"type":"book","title":"See: Fernando I. Ortiz Crespo (1995) \"Fragoso, Monardes and pre-Chinchonian knowledge of Cinchona,\" Archives of Natural History, 22 (2) : 169–181. David C. Stuart, Dangerous Garden: The Quest for Plants to Change Our Lives (London, England: Frances Lincoln Ltd., 2004), p. 28. Archived 4 6月 2016 at the Wayback Machine Nicolás Monardes, Primera, segunda y tercera partes de la Historia Medicinal de las cosas que le traen de nuestras Indias Occidentales y que sirven en Medicina [First, second and third parts of the medical history of things that have been brought from the new West Indies and that are of use in medicine] (Seville, Spain: Fernando Diaz, 1580), pp. 74-75. Archived 8 5月 2016 at the Wayback Machine From p. 74: \"Del nuevo Reyno, traen una corteza, que dizen ser de un arbol, que es de mucha grandeza: el qual dize, que lleva unas hojas de forma de coraçon, y que no lleva fruto. Este arbol tiene una corteza gruessa, muy solida y dura, que en esto y en el color parece mucho a la corteza del palo que llaman Guayacan: en la superfiecie tiene una pelicula delgada blanquisca, quebrada por toda ella: tiene la corteza mas de un dedo de gruesso, solida, y pesada: la qual gustada tiene notable amargor, como el dela Genciana: tiene en el gusto notable astriction, con alguna aromaticidad, porque al fin del mascar la respira della buen olor. Tienen los Indios esta corteza en mucho, y usan de lla en todo genero de camaras, que sean con sangre, o sin ella. Los Españoles fatigados de aquesta enfermedad, por aviso de los Indios, han usado de aquesta corteza y han sanado muchos del los con ella. Toman della tanto como una hava pequeña hecha poluos, toma se en vino tinto, o en agua apropiada, como tienen la calentura, o mal: ha se de tomar por la mañana en ayunas, tres o quatro vezes: usando en lo demas, la orden y regimiento que conviene a los que tienen camaras.\" (From the new kingdom, there is brought a bark, which is said to be from a tree, which is very large: it is said that it bears leaves in the form of a heart, and that it bears no fruit. This tree has a thick bark, very solid and hard, that in this and in its color looks much like the bark of the tree that is called guayacán [i.e., lignum vitae]: on the surface, it has a thin, discontinuous whitish film throughout it: it has bark more than one finger thick, solid and heavy: which, when tasted, has a considerable bitterness, like that of the gentian: it has in its taste a considerable astringency, with some aromaticity, because at the end of chewing it, one breathes with a sweet odor. The Indians hold this bark in high regard, and use it for all sorts of diarrhea, that are with blood [i.e., bloody] and without it. The Spanish [who are] tired of this disease, on the advice of the Indians, have used this bark and have healed many of those with it. They take as much as a small bean, make [it into] powder, take it in red wine or in appropriate water, if they have fever or illness: it must be taken in the morning on an empty stomach, three or four times: otherwise, using the order and regimen that suits those who have diarrhea.) Fragoso, Juan, Discursos de las cosas Aromáticas, árboles y frutales, y de otras muchas medicinas simples que se traen de la India y Oriental y sirven al uso de la medicina [Discourse on fragrant things, trees and fruits, as well as many other ordinary medicines that have been brought from India and the Orient and are of use to medicine] (Madrid, Spain: Francisco Sanchez, 1572), p. 35. Archived 5 5月 2016 at the Wayback Machine From p. 35: \"En el nuevo mundo ay un grande arbol que lleva las hojas a forma de coraçon, y carece de fruto. Tiene dos cortezas, la una gruessa muy solida dura, que assi en la sustancia como en el color es muy semejante al Guayacan: la otra es mas delgada y blaquezina, la qual es amarga con alguna estipticidad: y de mas desto es aromatica. Tienen la en mucho nuestros Indios, porque la usan contra qualesquier camaras, tomando de poluo peso de uno drama o poco mas, desatado en agua azerada, o vino tinto.\" (In the new world, there is a big tree that bears leaves in the form of a heart, and lacks fruit. It has two barks, one [is] thick, very solid, [and] hard, which in substance as well as in color is much like guayacan [i.e., lignum vitae]: the other is thinner and whitish, which is bitter with some styptic [i.e., astringent] quality: and besides this, it is aromatic. Our Indians regard it highly, because they use it against any diarrheas, taking a weight of a dram or a bit more of the powder, mixing it in mineral water, or red wine.)","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":38,"type":"book","title":"Juan Eusebio Nieremberg and Alonso de Andrade, Varones Ilustres en Santidad, Letras, y Zelo de las Almas. De la Compañia de Jesus. [Illustrious men in holiness, letters, and zeal for souls. Of the Society of Jesus (i.e., Jesuits).] (Madrid, Spain: Joseph Fernandez de Buendia, 1666), vol. 5, Vida del devoto Hermano Agustin Salumbrino (The life of the devout Brother Agustin Salumbrino), pp. 612–628 ; see p. 612. Archived 22 5月 2016 at the Wayback Machine From p. 612: \"Nacio el Hermano Agustin Salumbrino el año de mil y quinientos y sesenta y quatro en la Ciudad de Flori en le Romania, … \" (Brother Agustino Salumbrino was born in the year 1564 in the city of Flori [Note: This is an error; he was born in Forli.] in Emilia-Romagna, … )","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":39,"type":"book","title":"See: Francisco Medina Rodríguez (July 2007) \"Precisiones sobre la historia de la quina\" Archived 4 3月 2016 at the Wayback Machine (Details about the history of quinine), Reumatología Clínica, 3 (4) : 194–196. (in Spanish) From p. 195: \"De hecho, aunque no esté dicha la ultima palabra, hay escritos jesuitas que mencionan que la quina llegó a Roma en 1632, con el provincial de las missiones jusuitas del Perú, el padre Alonso Messia Venegas, como su introductor, cuando trajo una muestra de la corteza para presentaria como primicia, quien había partido de Lima 2 años antes, ya que consta que estuvo en Sevilla en 1632, donde publicó uno de sus libros y siguió su camino hacia Roma en calidad de procurador.\" (In fact, however, it is not the last word: there are Jesuit writings that mention that quinine arrived in Rome in 1632, with the provincial of the Jesuit missions of Peru, Father Alonso Messia Venegas, as its introducer, when he brought a sample of the bark so that it could be presented as a novelty, which had left Lima two years before, since in fact it had been in Seville in 1632, where he published one of his books and [then] he went his way toward Rome in the capacity of procurator.) Enrique Torres Saldamando, Los Antiguos Jesuitas del Perú [The old Jesuits of Peru] (Lima, Peru: Imprenta Liberal, 1882), pp. 180-191 ; see especially p. 181. Archived 10 4月 2016 at the Wayback Machine (in Spanish) From p. 181: \"Al siguiente año se dirigieron á Europa los Procuradores P. Alonso Messía Venegas y P. Hernando de Leon Garavito, llevando gran cantidad de la corteza de la quina, cuyo conocimiento extendieron por el mundo los jesuitas.\" (In the following year [i.e., 1631] there went to Europe the procurators Father Alonso Messia Venegas and Father Hernando de Leon Garavito, taking a great quantity of cinchona bark, knowledge of which the Jesuits spread throughout the world.) Alberto Bailetti, Blog: \"La Misión del Jesuita AgustÍn Salumbrino, la malaria y el árbol de quina\" Archived 4 3月 2016 at the Wayback Machine (The mission of the Jesuit Agustin Salumbrino, malaria and the quinine tree), Chapter 10: La Condensa de Chinchón (The countess of Chinchon). (in Spanish) From Chapter 10: \"A últimas horas de la tarde del treinta y uno de mayo de 1631 se hizo a la vela la armada real con dirección a Panamá llevando el millonario cargamento de oro y plata. En una de las naves viajaban los procuradores jesuitas padres Alonso Messia y Hernando León Garavito custodiando los fardos con la corteza de quina en polvo, preparados por Salumbrino. Después de casi veinte días de navegación el inapreciable medicamento llegó a la ciudad de Panamá, donde fue descargado para cruzar en mulas el agreste camino del itsmo palúdico hasta Portobelo para seguir a Cartagena y la Habana, cruzar el Atlántico y llegar a Sanlúcar de Barrameda en Sevilla. … Finalmente siguió su camino a Roma y a su destino final el Hospital del Espíritu Santo.\" (Late in the afternoon of the 31st of May, 1631, the royal armada set sail in the direction of Panama, carrying its multimillion [dollar] cargo of gold and silver. On one of the ships traveled the Jesuit procurators Fathers Alonso Messia and Hernando León Garavito, guarding the cases of powdered cinchona bark, prepared by Salumbrino. After almost 20 days of sailing, medicine arrived in the city of Panama, where it was transloaded onto mules. It then traveled the malarial isthmus as far as Portobelo, thence to Cartagena [in Colombia] and Havana. It then traveled to Sanlúcar de Barrameda in Seville, [Spain]. … Finally it followed the road to Rome and to its final destination, the Hospital of the Holy Spirit.)","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":40,"type":"book","title":"Rocco F (2004). Quinine: malaria and the quest for a cure that changed the world. New York, NY: Perennial.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":41,"type":"book","title":"Loren H (2000). Quinine and Quarantine.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":42,"type":"book","title":"de la Condamine (1738) \"Sur l'arbre du quinquina\" Archived 7 5月 2016 at the Wayback Machine (On the quinquina tree) Histoire de l'Académie royale des Sciences, pp. 226–243.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":43,"type":"book","title":"See also: Joseph de Jussieu, Description de l'arbre à quinquina: mémoire inédit de Joseph de Jussieu (1737) Archived 19 7月 2012 at the Wayback Machine (Description of the quinquina tree: unpublished memoir of Joseph de Jussieu (1737)). De Jussieu accompanied de la Condamine on the latter's expedition to Peru.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":44,"type":"book","title":"Pelletier and Caventou (1820) \"Suite: Des recherches chimiques sur les quinquinas\" Archived 4 5月 2016 at the Wayback Machine (Continuation: Chemical research on quinquinas), Annales de Chimie et de Physique, vol. 15, pages 337-365. The authors name quinine on page 348: \" …, nous avons cru devoir la nommer quinine, pour la distinguer de la cinchonine par un nom qui indique également son origine.\" ( …, we thought that we should name it \"quinine\" in order to distinguish it from cinchonine by means of a name that also indicates its origin.)","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":45,"type":"book","title":"Paul Briquet (1853) Traité thérapeutique du quinquina et de ses preparations from Internet Archive","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":46,"type":"book","title":"Conner, Clifford D. (2005). A People's History of Science: Miners, Midwives, and 'Low Mechanicks'. New York: Nation Books. pp. 95–96. ISBN 978-1-56025-748-6. Also cites Porter, Roy (1998). The Greatest Benefit to Mankind: A Medical History of Humanity. New York: W. W. Norton. pp. 465–466. ISBN 978-0-393-04634-2.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":47,"type":"book","title":"Shah S (2010). The Fever: How Malaria Has Ruled Humankind for 500,000 Years (in 英语). Farrar, Straus and Giroux. p. 94.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":48,"type":"book","title":"Louis Morton (1953). \"29\". The Fall of the Philippines. Washington, D.C.: United States Army. p. 524. Archived from the original on 25 May 2017.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":49,"type":"book","title":"Alan Hawk. \"Remembering the war in New Guinea: Japanese Medical Corps – malaria\". Archived from the original on 22 November 2011.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":50,"type":"book","title":"\"Notes on Japanese Medical Services\". Tactical and Technical Trends (36). 1943. Archived from the original on 14 October 2011.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":51,"type":"book","title":"Lt. Gen. Leonard D. Heaton, ed. (1963). \"8\". Preventive Medicine in World War II: Volume VI, Communicable Diseases: Malaria. Washington, D.C.: Department of the Army. pp. 401 and 434. Archived from the original on 29 January 2012.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":52,"type":"book","title":"Shah S (2010). The Fever: How Malaria Has Ruled Humankind for 500,000 Years (in 英语). Farrar, Straus and Giroux. p. 102.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":53,"type":"book","title":"\"Medicine: What's Good for a Cold?\". Time. 22 February 1960. Archived from the original on 26 July 2010. Retrieved 27 April 2010.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":54,"type":"book","title":"\"FDA Orders Stop to Marketing Of Quinine for Night Leg Cramps\". FDA Consumer Magazine. Food and Drug Administration. July–August 1995. Archived from the original on 2008-01-15. Retrieved 2009-07-31.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":55,"type":"book","title":"\"FDA Orders Unapproved Quinine Drugs from the Market and Cautions Consumers About Off-Label Use of Quinine to Treat Leg Cramps\". United States Food and Drug Administration. 11 December 2006. Archived from the original on 28 July 2009. Retrieved 31 July 2009.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":56,"type":"book","title":"\"Malaria Surveillance - United States, 2004\". Center for Disease Control. 22 November 2006. Archived from the original on 18 November 2009. Retrieved 22 November 2009.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":57,"type":"book","title":"Microgram Bulletin, Volume 42, Number 10, October 2009 Archived 17 10月 2012 at the Wayback Machine, Page 79. Retrieved 22 September 2012.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":58,"type":"book","title":"Porritt, M., Cryptocaryon irritans Archived 24 10月 2009 at the Wayback Machine, Reef Culture Magazine, 1. Retrieved 9th Jul 2009","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false}],"recommendReferences":null,"auditState":2,"lemmaLevel":1,"origin":0,"originEnTitle":null,"originZhTitle":null,"pv":9921,"auditType":2,"synonyms":["金鸡纳霜","鸡纳碱","规宁","金鸡纳碱"],"showEditTime":"2020.08.25 12:35","auditors":[{"uid":5567290,"name":"人间小太阳","pic":"https://web.archive.org/web/20221028211208/https://cache.soso.com/qlogo/g?b=oidb&k=4xjGfuUZbbjZEI7OAVIVEg&s=100&t=1609215301","introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":"","jobBrief":"","role":0,"roleName":null,"title":"","professionalTitle":null,"phoneNo":null,"editable":true,"partnerId":250,"partnerIdCreateTime":1598322359,"partnerIdPoped":true}],"hasZhishiNav":true,"auditInfos":{"0":[{"versionId":"0","auditTime":1598337160,"auditorId":5567290,"auditUser":{"uid":5567290,"name":"人间小太阳","pic":"https://web.archive.org/web/20221028211208/https://cache.soso.com/qlogo/g?b=oidb&k=4xjGfuUZbbjZEI7OAVIVEg&s=100&t=1609215301","introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":"","jobBrief":"","role":0,"roleName":null,"title":"","professionalTitle":null,"phoneNo":null,"editable":true,"partnerId":250,"partnerIdCreateTime":1598322359,"partnerIdPoped":true},"auditReason":"","auditSuggest":"简单修改","auditResult":2,"auditAnnotations":null}]},"isHistory":false};</script><script crossorigin="anonymous" src="./14.奎宁 - 搜狗科学百科_files/aegis.min.js.download"></script><script crossorigin="anonymous" src="./14.奎宁 - 搜狗科学百科_files/main_2020092401.js.download"></script><script crossorigin="anonymous" src="./14.奎宁 - 搜狗科学百科_files/react.production.min.js.download"></script><script crossorigin="anonymous" src="./14.奎宁 - 搜狗科学百科_files/react-dom.production.min.js.download"></script><script crossorigin="anonymous" src="./14.奎宁 - 搜狗科学百科_files/jquery-1.11.1.min.js.download"></script><script crossorigin="anonymous" src="./14.奎宁 - 搜狗科学百科_files/main_2022062701.js.download"></script><script crossorigin="anonymous" src="./14.奎宁 - 搜狗科学百科_files/main_66bbe21.js.download"></script><script crossorigin="anonymous" src="./14.奎宁 - 搜狗科学百科_files/react.production.min.js.download"></script><script crossorigin="anonymous" src="./14.奎宁 - 搜狗科学百科_files/react-dom.production.min.js.download"></script><script crossorigin="anonymous" src="./14.奎宁 - 搜狗科学百科_files/main_edf0f08.js.download"></script>
</body></html>